{ "instance": { "hct-20220331.htm": { "axisCustom": 2, "axisStandard": 39, "contextCount": 367, "dts": { "calculationLink": { "local": [ "hct-20220331_cal.xml" ] }, "definitionLink": { "local": [ "hct-20220331_def.xml" ] }, "inline": { "local": [ "hct-20220331.htm" ] }, "labelLink": { "local": [ "hct-20220331_lab.xml" ] }, "presentationLink": { "local": [ "hct-20220331_pre.xml" ] }, "schema": { "local": [ "hct-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 713, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 2, "http://www.thehealthcarereit2.com/20220331": 2, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 9 }, "keyCustom": 95, "keyStandard": 311, "memberCustom": 91, "memberStandard": 53, "nsprefix": "hct", "nsuri": "http://www.thehealthcarereit2.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.thehealthcarereit2.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108103 - Disclosure - Real Estate Investments, Net", "role": "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNet", "shortName": "Real Estate Investments, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116104 - Disclosure - Mortgage Notes Payable, Net", "role": "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNet", "shortName": "Mortgage Notes Payable, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2120105 - Disclosure - Credit Facilities", "role": "http://www.thehealthcarereit2.com/role/CreditFacilities", "shortName": "Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2125106 - Disclosure - Fair Value of Financial Instruments", "role": "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2130107 - Disclosure - Derivatives and Hedging Activities", "role": "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivities", "shortName": "Derivatives and Hedging Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2137108 - Disclosure - Stockholders' Equity", "role": "http://www.thehealthcarereit2.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2141109 - Disclosure - Related Party Transactions and Arrangements", "role": "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangements", "shortName": "Related Party Transactions and Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "hct:EconomicDependencyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2147110 - Disclosure - Economic Dependency", "role": "http://www.thehealthcarereit2.com/role/EconomicDependency", "shortName": "Economic Dependency", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "hct:EconomicDependencyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2148111 - Disclosure - Equity-Based Compensation", "role": "http://www.thehealthcarereit2.com/role/EquityBasedCompensation", "shortName": "Equity-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2152112 - Disclosure - Accumulated Other Comprehensive Loss", "role": "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2155113 - Disclosure - Non-controlling Interests", "role": "http://www.thehealthcarereit2.com/role/NoncontrollingInterests", "shortName": "Non-controlling Interests", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2160114 - Disclosure - Net Loss Per Share", "role": "http://www.thehealthcarereit2.com/role/NetLossPerShare", "shortName": "Net Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2164115 - Disclosure - Segment Reporting", "role": "http://www.thehealthcarereit2.com/role/SegmentReporting", "shortName": "Segment Reporting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2170116 - Disclosure - Commitments and Contingencies", "role": "http://www.thehealthcarereit2.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2174117 - Disclosure - Subsequent Events", "role": "http://www.thehealthcarereit2.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309302 - Disclosure - Real Estate Investments, Net (Tables)", "role": "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetTables", "shortName": "Real Estate Investments, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2317303 - Disclosure - Mortgage Notes Payable, Net (Tables)", "role": "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetTables", "shortName": "Mortgage Notes Payable, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321304 - Disclosure - Credit Facilities (Tables)", "role": "http://www.thehealthcarereit2.com/role/CreditFacilitiesTables", "shortName": "Credit Facilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2326305 - Disclosure - Fair Value of Financial Instruments (Tables)", "role": "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2331306 - Disclosure - Derivatives and Hedging Activities (Tables)", "role": "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesTables", "shortName": "Derivatives and Hedging Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2338307 - Disclosure - Stockholders' Equity (Tables)", "role": "http://www.thehealthcarereit2.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "hct:ScheduleOfAmountContractuallyDueAndForgivenInConnectionWithOperationRelatedServicesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2342308 - Disclosure - Related Party Transactions and Arrangements (Tables)", "role": "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsTables", "shortName": "Related Party Transactions and Arrangements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "hct:ScheduleOfAmountContractuallyDueAndForgivenInConnectionWithOperationRelatedServicesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2349309 - Disclosure - Equity-Based Compensation (Tables)", "role": "http://www.thehealthcarereit2.com/role/EquityBasedCompensationTables", "shortName": "Equity-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2353310 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "role": "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "hct:NoncontrollingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2356311 - Disclosure - Non-controlling Interests (Tables)", "role": "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsTables", "shortName": "Non-controlling Interests (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "hct:NoncontrollingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2361312 - Disclosure - Net Loss Per Share (Tables)", "role": "http://www.thehealthcarereit2.com/role/NetLossPerShareTables", "shortName": "Net Loss Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2365313 - Disclosure - Segment Reporting (Tables)", "role": "http://www.thehealthcarereit2.com/role/SegmentReportingTables", "shortName": "Segment Reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2371314 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)", "role": "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostsAndExpensesRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402401 - Disclosure - Organization (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "shortName": "Organization (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:NumberOfStatesInWhichEntityOperates", "reportCount": 1, "unique": true, "unitRef": "state", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "3", "first": true, "lang": "en-US", "name": "hct:RentCollectionPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary of Significant Accounting Policies (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "3", "first": true, "lang": "en-US", "name": "hct:RentCollectionPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies (Lessor Maturity Schedule) (Details)", "role": "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails", "shortName": "Summary of Significant Accounting Policies (Lessor Maturity Schedule) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Real Estate Investments, Net (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "shortName": "Real Estate Investments, Net (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i120f1ac25aa3448cb5f032cbc4ad6d98_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i10daf916ab04491a882c85aa80b12588_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "hct:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLandAcquiredinPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - Real Estate Investments, Net (Acquired Assets) (Details)", "role": "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails", "shortName": "Real Estate Investments, Net (Acquired Assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i10daf916ab04491a882c85aa80b12588_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "hct:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLandAcquiredinPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i30f58d5a5933433ab114ee9de4c308f3_D20220101-20220331", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - Real Estate Investments, Net (Geographic Concentrations) (Details)", "role": "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails", "shortName": "Real Estate Investments, Net (Geographic Concentrations) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i30f58d5a5933433ab114ee9de4c308f3_D20220101-20220331", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "hct:AccretionOfBelowMarketLeaseLiabilitiesAndAmortizationOfAboveMarketLeaseAssetsNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413407 - Disclosure - Real Estate Investments, Net (Summary of Amortization and Accretion Recognized) (Details)", "role": "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails", "shortName": "Real Estate Investments, Net (Summary of Amortization and Accretion Recognized) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "if90d3304acef45878b8c77a14a9cf031_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i707365a2387b4b71b287daf65f6e3882_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414408 - Disclosure - Real Estate Investments, Net (Summary of Intangible Assets and Liabilities Future Amortization Expense) (Details)", "role": "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails", "shortName": "Real Estate Investments, Net (Summary of Intangible Assets and Liabilities Future Amortization Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i707365a2387b4b71b287daf65f6e3882_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfRealEstate", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415409 - Disclosure - Real Estate Investments, Net (Impairments) (Details)", "role": "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetImpairmentsDetails", "shortName": "Real Estate Investments, Net (Impairments) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418410 - Disclosure - Mortgage Notes Payable, Net (Mortgage Notes) (Details)", "role": "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "shortName": "Mortgage Notes Payable, Net (Mortgage Notes) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ic9104ed450cc4938a2837db96ea43286_I20220331", "decimals": "INF", "lang": "en-US", "name": "hct:NumberOfRealEstatePropertiesEncumbered", "reportCount": 1, "unique": true, "unitRef": "property", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i79177a4651eb4885b7b47db09574ceab_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "role": "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i79177a4651eb4885b7b47db09574ceab_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-8", "first": true, "lang": "en-US", "name": "hct:RealEstateInvestmentAtCostRelatingtoNotesPayable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419411 - Disclosure - Mortgage Notes Payable, Net (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetNarrativeDetails", "shortName": "Mortgage Notes Payable, Net (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422412 - Disclosure - Credit Facilities (Summary of Credit Facilities) (Details)", "role": "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "shortName": "Credit Facilities (Summary of Credit Facilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ib43237e3a45b44e48e1a14eb862e9ffa_I20220331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unique": true, "unitRef": "property", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RealEstateInvestmentPropertyAtCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423413 - Disclosure - Credit Facilities (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "shortName": "Credit Facilities (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "INF", "lang": "en-US", "name": "hct:DebtInstrumentCovenantsMinimumCashCashEquivalentsandBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424414 - Disclosure - Credit Facilities (Future Principal Payments of Outstanding Debt) (Details)", "role": "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "shortName": "Credit Facilities (Future Principal Payments of Outstanding Debt) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i3737c539e53a43dc977ea530ac198237_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427415 - Disclosure - Fair Value of Financial Instruments (Assets Measured at Fair Value) (Details)", "role": "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails", "shortName": "Fair Value of Financial Instruments (Assets Measured at Fair Value) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i3737c539e53a43dc977ea530ac198237_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie5935997ac5346ce9d4323c2e3ce0485_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "hct:DisposalGroupIncludingDiscontinuedOperationNumberOfPropertiesHeldForUse", "reportCount": 1, "unique": true, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428416 - Disclosure - Fair Value of Financial Instruments (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails", "shortName": "Fair Value of Financial Instruments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie5935997ac5346ce9d4323c2e3ce0485_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "hct:DisposalGroupIncludingDiscontinuedOperationNumberOfPropertiesHeldForUse", "reportCount": 1, "unique": true, "unitRef": "property", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ic21f3f2b63064e9aa66e46cac34b6347_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429417 - Disclosure - Fair Value of Financial Instruments (Carrying Amounts and Fair Values of Debt) (Details)", "role": "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails", "shortName": "Fair Value of Financial Instruments (Carrying Amounts and Fair Values of Debt) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ic21f3f2b63064e9aa66e46cac34b6347_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432418 - Disclosure - Derivatives and Hedging Activities (Balance Sheet Classification) (Details)", "role": "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "shortName": "Derivatives and Hedging Activities (Balance Sheet Classification) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ib262d6e7f911487e902138593193b39d_I20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433419 - Disclosure - Derivatives and Hedging Activities (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "shortName": "Derivatives and Hedging Activities (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DerivativeNetLiabilityPositionAggregateFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "hct:NumberOfInterestRateDerivativesNotYetInEffect", "reportCount": 1, "unique": true, "unitRef": "derivative", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434420 - Disclosure - Derivatives and Hedging Activities (Summary of Derivative Instruments) (Details)", "role": "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails", "shortName": "Derivatives and Hedging Activities (Summary of Derivative Instruments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "hct:NumberOfInterestRateDerivativesNotYetInEffect", "reportCount": 1, "unique": true, "unitRef": "derivative", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical)", "role": "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i259ae1cd7f5c45ddb4e7370c53dfd58c_D20220101-20220331", "decimals": "2", "lang": "en-US", "name": "us-gaap:PreferredStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435421 - Disclosure - Derivatives and Hedging Activities (Derivatives Included in AOCI) (Details)", "role": "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails", "shortName": "Derivatives and Hedging Activities (Derivatives Included in AOCI) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i37ca8175abd240c1afb9c58622a753ed_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436422 - Disclosure - Derivatives and Hedging Activities (Offsetting Derivatives) (Details)", "role": "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails", "shortName": "Derivatives and Hedging Activities (Offsetting Derivatives) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439423 - Disclosure - Stockholders' Equity (Schedule of Stock by Class) (Details)", "role": "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails", "shortName": "Stockholders' Equity (Schedule of Stock by Class) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "lang": "en-US", "name": "hct:DRIPPeriodofNoticetoAlterAgreement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockSharesAcquired", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440424 - Disclosure - Stockholders' Equity (Cumulative Share Repurchases) (Details)", "role": "http://www.thehealthcarereit2.com/role/StockholdersEquityCumulativeShareRepurchasesDetails", "shortName": "Stockholders' Equity (Cumulative Share Repurchases) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockSharesAcquired", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesIssued", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2443425 - Disclosure - Related Party Transactions and Arrangements (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails", "shortName": "Related Party Transactions and Arrangements (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ied2026d2f1bc461a89c29ee345fe630b_I20220331", "decimals": "INF", "lang": "en-US", "name": "hct:RelatedPartyTransactionSpecialAllocationforTaxPurposesExcessDepreciationDeductionsMaximum", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i03b4d21e976a4ffb8debed744c59a485_D20170217-20170217", "decimals": null, "first": true, "lang": "en-US", "name": "hct:RelatedPartyAgreementTermofAgreementRenewalPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444426 - Disclosure - Related Party Transactions and Arrangements (Fees Paid in Connection With the Operations of the Company) (Details)", "role": "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "shortName": "Related Party Transactions and Arrangements (Fees Paid in Connection With the Operations of the Company) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i03b4d21e976a4ffb8debed744c59a485_D20170217-20170217", "decimals": null, "first": true, "lang": "en-US", "name": "hct:RelatedPartyAgreementTermofAgreementRenewalPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "hct:ScheduleOfAmountContractuallyDueAndForgivenInConnectionWithOperationRelatedServicesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i0be0e0671b7e419ebcda745fc4864407_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2445427 - Disclosure - Related Party Transactions and Arrangements (Fees Paid in Connection With the Operations of the Company, Incurred, Forgiven and Payable) (Details)", "role": "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "shortName": "Related Party Transactions and Arrangements (Fees Paid in Connection With the Operations of the Company, Incurred, Forgiven and Payable) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "hct:ScheduleOfAmountContractuallyDueAndForgivenInConnectionWithOperationRelatedServicesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i0be0e0671b7e419ebcda745fc4864407_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia14e8950a10d44af96dd47f2aa56de8d_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "hct:RelatedPartyTransactionSubordinatedIncentiveListingDistributionPercentageOfBenchmark", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446428 - Disclosure - Related Party Transactions and Arrangements (Fees and Participations Paid in Connection with the Liquidation or Listing of the Company's Real Estate Assets) (Details)", "role": "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "shortName": "Related Party Transactions and Arrangements (Fees and Participations Paid in Connection with the Liquidation or Listing of the Company's Real Estate Assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia14e8950a10d44af96dd47f2aa56de8d_I20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "hct:RelatedPartyTransactionSubordinatedIncentiveListingDistributionPercentageOfBenchmark", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i1342217488084affbe2d0d2512de4cfa_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2450429 - Disclosure - Equity-Based Compensation (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "shortName": "Equity-Based Compensation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i1342217488084affbe2d0d2512de4cfa_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ibea8ab823bc14d678b2e641a9b867f95_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451430 - Disclosure - Equity-Based Compensation (Summary of Activity) (Details)", "role": "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails", "shortName": "Equity-Based Compensation (Summary of Activity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i461f80a144f34c09a50cd806c38195e1_D20220101-20220331", "decimals": "INF", "lang": "en-US", "name": "hct:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsStockDividend", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ibadfa830f20747e487e8c83766176bd7_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2454431 - Disclosure - Accumulated Other Comprehensive Loss (Summary of Changes in AOCI) (Details)", "role": "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "shortName": "Accumulated Other Comprehensive Loss (Summary of Changes in AOCI) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "if75b7617436e44358ce5a14bfdea6a87_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "hct:NoncontrollingInterestTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestInOperatingPartnerships", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2457432 - Disclosure - Non-controlling Interests - Balance Sheet Breakdown (Details)", "role": "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails", "shortName": "Non-controlling Interests - Balance Sheet Breakdown (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "hct:NoncontrollingInterestTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestInOperatingPartnerships", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsOfDividendsMinorityInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2458433 - Disclosure - Non-controlling Interests (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "shortName": "Non-controlling Interests (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "INF", "lang": "en-US", "name": "us-gaap:PaymentsToMinorityShareholders", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "hct:NoncontrollingInterestTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2459434 - Disclosure - Non-controlling Interests (Summary of Non-controlling Interests) (Details)", "role": "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails", "shortName": "Non-controlling Interests (Summary of Non-controlling Interests) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ifabfbeb1c22741deb9bf1bd1022f2236_I20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:MinorityInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2462435 - Disclosure - Net Loss Per Share (Summary of Basic and Diluted Net Loss Per Share Computation) (Details)", "role": "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofBasicandDilutedNetLossPerShareComputationDetails", "shortName": "Net Loss Per Share (Summary of Basic and Diluted Net Loss Per Share Computation) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2463436 - Disclosure - Net Loss Per Share (Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share) (Details)", "role": "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "shortName": "Net Loss Per Share (Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2466437 - Disclosure - Segment Reporting (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/SegmentReportingNarrativeDetails", "shortName": "Segment Reporting (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2467438 - Disclosure - Segment Reporting (Reconciliation of Segment Activity) (Details)", "role": "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails", "shortName": "Segment Reporting (Reconciliation of Segment Activity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RealEstateInvestmentPropertyNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2468439 - Disclosure - Segment Reporting (Reconciliation of Segment Activity to Assets) (Details)", "role": "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails", "shortName": "Segment Reporting (Reconciliation of Segment Activity to Assets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "id28541e97a384f0987665b2e211ab07a_I20220331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RealEstateInvestmentPropertyNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ic8f5bd1a36074b21be8d600c7dcd0548_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2469440 - Disclosure - Segment Reporting (Reconciliation of Capital Expenditures by Segment) (Details)", "role": "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails", "shortName": "Segment Reporting (Reconciliation of Capital Expenditures by Segment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ic8f5bd1a36074b21be8d600c7dcd0548_D20220101-20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Organization", "role": "http://www.thehealthcarereit2.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "hct:LesseeOperatingLeaseNumberOfContracts", "reportCount": 1, "unique": true, "unitRef": "lease", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2472441 - Disclosure - Commitments and Contingencies (Narrative) (Details)", "role": "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": "INF", "first": true, "lang": "en-US", "name": "hct:LesseeOperatingLeaseNumberOfContracts", "reportCount": 1, "unique": true, "unitRef": "lease", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2473442 - Disclosure - Commitments and Contingencies (Schedule of Future Minimum Rental Payments) (Details)", "role": "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails", "shortName": "Commitments and Contingencies (Schedule of Future Minimum Rental Payments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ia298b266b5304c66b9a1ef6cf50fc34a_I20220331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "i155627f31edd44b69e076626cf3e01dc_D20201001-20201001", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockDividendsShares", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2475443 - Disclosure - Subsequent Events (Details)", "role": "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ic4ec43af23fe488c8ebe0d89e17d9b29_I20220430", "decimals": "4", "lang": "en-US", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hct-20220331.htm", "contextRef": "ie8547113ed544549a4cf677f1f8b8272_D20220101-20220331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 150, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r631" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r633" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r629" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.thehealthcarereit2.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "hct_A2020BonusAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Bonus Awards", "label": "2020 Bonus Awards [Member]", "terseLabel": "2020 Bonus Awards" } } }, "localname": "A2020BonusAwardsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_AboveMarketGroundLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Above Market Ground Lease [Member]", "label": "Above Market Ground Lease [Member]", "terseLabel": "Above market ground leases" } } }, "localname": "AboveMarketGroundLeaseMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails" ], "xbrltype": "domainItemType" }, "hct_AboveandBelowMarketLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Above and Below Market Leases [Member]", "label": "Above and Below Market Leases [Member]", "terseLabel": "Above and Below Market Leases" } } }, "localname": "AboveandBelowMarketLeasesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails" ], "xbrltype": "domainItemType" }, "hct_AccretionOfBelowMarketLeaseLiabilitiesAndAmortizationOfAboveMarketLeaseAssetsNet": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment for noncash decrease (increase) in rental revenue related to assets (liabilities) associated with the acquisition of an off-market lease when the terms of the lease are favorable (unfavorable) to the market terms for the lease at the date of acquisition.", "label": "Accretion of Below-Market Lease Liabilities and Amortization of Above-Market Lease Assets, Net", "terseLabel": "Accretion of market lease and other intangibles, net", "verboseLabel": "Accretion of above-and below-market leases, net" } } }, "localname": "AccretionOfBelowMarketLeaseLiabilitiesAndAmortizationOfAboveMarketLeaseAssetsNet", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "hct_AcquisitionCostsReimbursementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition Costs Reimbursements [Member]", "label": "Acquisition Costs Reimbursements [Member]", "terseLabel": "Acquisition cost reimbursements" } } }, "localname": "AcquisitionCostsReimbursementsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_AdjustmentstoAdditionalPaidinCapitalRebalancingOfOwnershipPercentage": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to Additional Paid in Capital, Rebalancing Of Ownership Percentage", "label": "Adjustments to Additional Paid in Capital, Rebalancing Of Ownership Percentage", "terseLabel": "Rebalancing of ownership percentage" } } }, "localname": "AdjustmentstoAdditionalPaidinCapitalRebalancingOfOwnershipPercentage", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "hct_AdvanceOnLoanOrOtherInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advance on Loan or Other Investment [Member]", "label": "Advance on Loan or Other Investment [Member]", "terseLabel": "Advance on Loan or Other Investment" } } }, "localname": "AdvanceOnLoanOrOtherInvestmentMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_AdvisorAndCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisor And Company [Member]", "label": "Advisor And Company [Member]", "terseLabel": "Advisor And Company" } } }, "localname": "AdvisorAndCompanyMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_AdvisorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisor [Member]", "label": "Advisor [Member]", "terseLabel": "Advisor" } } }, "localname": "AdvisorMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_AmendedandRestatedPropertyManagementandLeasingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended and Restated Property Management and Leasing Agreement [Member]", "label": "Amended and Restated Property Management and Leasing Agreement [Member]", "terseLabel": "Amended and Restated Property Management and Leasing Agreement" } } }, "localname": "AmendedandRestatedPropertyManagementandLeasingAgreementMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_AmericanRealtyCapitalHealthcareAdvisorsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American Realty Capital Healthcare Advisors, LLC [Member]", "label": "American Realty Capital Healthcare Advisors, LLC [Member]", "terseLabel": "American Realty Capital Healthcare Advisors, LLC" } } }, "localname": "AmericanRealtyCapitalHealthcareAdvisorsLLCMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_AmericanRealtyCapitalHealthcareIIIAdvisorsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American Realty Capital Healthcare III Advisors, LLC [Member]", "label": "American Realty Capital Healthcare III Advisors, LLC [Member]", "terseLabel": "American Realty Capital Healthcare III Advisors, LLC" } } }, "localname": "AmericanRealtyCapitalHealthcareIIIAdvisorsLLCMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "hct_AmericanRealtyCapitalHealthcareIISpecialLimitedPartnershipLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American Realty Capital Healthcare II Special Limited Partnership, LLC [Member]", "label": "American Realty Capital Healthcare II Special Limited Partnership, LLC [Member]", "terseLabel": "American Realty Capital Healthcare II Special Limited Partnership, LLC" } } }, "localname": "AmericanRealtyCapitalHealthcareIISpecialLimitedPartnershipLLCMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_AmortizationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amortization Expense [Member]", "label": "Amortization Expense [Member]", "terseLabel": "Amortization Expense" } } }, "localname": "AmortizationExpenseMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "hct_AmortizationofTerminatedSwapPayment": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of Terminated Swap Payment", "label": "Amortization of Terminated Swap Payment", "terseLabel": "Amortization of terminated swap" } } }, "localname": "AmortizationofTerminatedSwapPayment", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "hct_AnnualTargetedInvestorReturnMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Annual Targeted Investor Return [Member]", "label": "Annual Targeted Investor Return [Member]", "terseLabel": "Annual Targeted Investor Return" } } }, "localname": "AnnualTargetedInvestorReturnMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_AssetManagementFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Management Fees [Member]", "label": "Asset Management Fees [Member]", "terseLabel": "Asset management fees" } } }, "localname": "AssetManagementFeesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_BMOMOBLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BMO MOB Loan", "label": "BMO MOB Loan [Member]", "terseLabel": "BMO CMBS Loan" } } }, "localname": "BMOMOBLoanMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "hct_BelowMarketLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Below Market Lease [Member]", "label": "Below Market Lease [Member]", "terseLabel": "Below-market lease liabilities" } } }, "localname": "BelowMarketLeaseMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "hct_BuildingsFixturesandImprovements": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Buildings, Fixtures and Improvements", "label": "Buildings, Fixtures and Improvements", "terseLabel": "Buildings, fixtures and improvements" } } }, "localname": "BuildingsFixturesandImprovements", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "hct_BusinessAcquisitionCostOfAcquiredEntityCashPaidInPeriod": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Acquisition Cost Of Acquired Entity Cash Paid In Period", "label": "Business Acquisition Cost Of Acquired Entity Cash Paid In Period", "totalLabel": "Cash paid for real estate investments, including acquisitions" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityCashPaidInPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "monetaryItemType" }, "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredinPeriodNet": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails": { "order": 1.0, "parentTag": "hct_BusinessAcquisitionCostOfAcquiredEntityCashPaidInPeriod", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired in Period, Net", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired in Period, Net", "totalLabel": "Total intangible assets and liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredinPeriodNet", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "monetaryItemType" }, "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBuildingFixturesandImprovementsCapitalLeasesAcquiredinPeriod": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails": { "order": 2.0, "parentTag": "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAcquiredDuringPeriod", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed Building, Fixtures and Improvements, Capital Leases, Acquired in Period", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed Building, Fixtures and Improvements, Capital Leases, Acquired in Period", "terseLabel": "Buildings, fixtures and improvements" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBuildingFixturesandImprovementsCapitalLeasesAcquiredinPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "monetaryItemType" }, "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangiblesAcquiredDuringThePeriod": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails": { "order": 1.0, "parentTag": "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredinPeriodNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles, Acquired During The Period", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles, Acquired During The Period", "terseLabel": "In-place leases, market leases, and other intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangiblesAcquiredDuringThePeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "monetaryItemType" }, "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLandAcquiredinPeriod": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails": { "order": 1.0, "parentTag": "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAcquiredDuringPeriod", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Acquired in Period", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Acquired in Period", "terseLabel": "Land" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLandAcquiredinPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "monetaryItemType" }, "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLeaseLiabilitiesAcquired": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails": { "order": 2.0, "parentTag": "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsAcquiredinPeriodNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities Acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Lease Liabilities Acquired", "negatedLabel": "Market lease liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedLeaseLiabilitiesAcquired", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "monetaryItemType" }, "hct_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAcquiredDuringPeriod": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails": { "order": 2.0, "parentTag": "hct_BusinessAcquisitionCostOfAcquiredEntityCashPaidInPeriod", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets Acquired During Period", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets Acquired During Period", "totalLabel": "Total tangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsAcquiredDuringPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "monetaryItemType" }, "hct_CapitalOneFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital One Facility [Member]", "label": "Capital One Facility [Member]", "terseLabel": "Capital One Facility" } } }, "localname": "CapitalOneFacilityMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "hct_CappedReimbursementAmountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capped Reimbursement Amount [Member]", "label": "Capped Reimbursement Amount [Member]", "terseLabel": "Capped Reimbursement Amount" } } }, "localname": "CappedReimbursementAmountMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_ChangeinControlFeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change in Control Fee [Member]", "label": "Change in Control Fee [Member]", "terseLabel": "Change in Control Fee" } } }, "localname": "ChangeinControlFeeMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_ClassBUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class B Units [Member]", "label": "Class B Units [Member]", "terseLabel": "Class B Units" } } }, "localname": "ClassBUnitsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "hct_CommencementQuarterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commencement Quarter [Member]", "label": "Commencement Quarter [Member]", "terseLabel": "Commencement Quarter" } } }, "localname": "CommencementQuarterMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_CommonOperatingPartnershipUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Operating Partnership Unit", "label": "Common Operating Partnership Unit [Member]", "terseLabel": "Common OP Unit" } } }, "localname": "CommonOperatingPartnershipUnitMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails" ], "xbrltype": "domainItemType" }, "hct_CommonShareEquivalentsSharesApprovedforIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Share Equivalents, Shares Approved for Issuance", "label": "Common Share Equivalents, Shares Approved for Issuance", "terseLabel": "Shares approved for issuance (in shares)" } } }, "localname": "CommonShareEquivalentsSharesApprovedforIssuance", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "sharesItemType" }, "hct_CommonShareEquivalentsSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Share Equivalents, Shares Outstanding", "label": "Common Share Equivalents, Shares Outstanding", "terseLabel": "Class B units (in shares)" } } }, "localname": "CommonShareEquivalentsSharesOutstanding", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "hct_CommonUnitIssuanceValueSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Unit, Issuance Value Share Price", "label": "Common Unit, Issuance Value Share Price", "terseLabel": "Units issued (in usd per share)" } } }, "localname": "CommonUnitIssuanceValueSharePrice", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "hct_ConsumerPriceIndexMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer Price Index [Member]", "label": "Consumer Price Index [Member]", "terseLabel": "Cost Of Living" } } }, "localname": "ConsumerPriceIndexMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_ContractPurchasePriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Purchase Price [Member]", "label": "Contract Purchase Price [Member]", "terseLabel": "Contract Purchase Price" } } }, "localname": "ContractPurchasePriceMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_CovenantPeriodAfterCommencementQuarterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Period After Commencement Quarter [Member]", "label": "Covenant Period After Commencement Quarter [Member]", "terseLabel": "Covenant Period After Commencement Quarter" } } }, "localname": "CovenantPeriodAfterCommencementQuarterMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_CovenantPeriodAfterJune302021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Period After June 30, 2021 [Member]", "label": "Covenant Period After June 30, 2021 [Member]", "terseLabel": "Covenant Period After June 30, 2021" } } }, "localname": "CovenantPeriodAfterJune302021Member", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_CovenantPeriodAfterNovember122021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Period After November 12, 2021", "label": "Covenant Period After November 12, 2021 [Member]", "terseLabel": "Covenant Period After November 12, 2021" } } }, "localname": "CovenantPeriodAfterNovember122021Member", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_CovenantPeriodAugust102020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Period August 10, 2020 [Member]", "label": "Covenant Period August 10, 2020 [Member]", "terseLabel": "Covenant Period August 10, 2020" } } }, "localname": "CovenantPeriodAugust102020Member", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_CovenantPeriodFromApril12021throughJune302021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Period From April 1, 2021 through June 30, 2021 [Member]", "label": "Covenant Period From April 1, 2021 through June 30, 2021 [Member]", "terseLabel": "Covenant Period From April 1, 2021 through June 30, 2021" } } }, "localname": "CovenantPeriodFromApril12021throughJune302021Member", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_CovenantPeriodFromJuly12021throughCommencementQuarterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Period From July 1, 2021 through Commencement Quarter [Member]", "label": "Covenant Period From July 1, 2021 through Commencement Quarter [Member]", "terseLabel": "Covenant Period From July 1, 2021 through Commencement Quarter" } } }, "localname": "CovenantPeriodFromJuly12021throughCommencementQuarterMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_CovenantPeriodJuly12020throughJune302021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Period July 1, 2020 through June 30, 2021 [Member]", "label": "Covenant Period July 1, 2020 through June 30, 2021 [Member]", "terseLabel": "Covenant Period July 1, 2020 through June 30, 2021" } } }, "localname": "CovenantPeriodJuly12020throughJune302021Member", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_CovenantPeriodJuly12020throughMarch312021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Period July 1, 2020 through March 31, 2021 [Member]", "label": "Covenant Period July 1, 2020 through March 31, 2021 [Member]", "terseLabel": "Covenant Period July 1, 2020 through March 31, 2021" } } }, "localname": "CovenantPeriodJuly12020throughMarch312021Member", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_DRIPPeriodofNoticetoAlterAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DRIP, Period of Notice to Alter Agreement", "label": "DRIP, Period of Notice to Alter Agreement", "terseLabel": "DRIP period of notice to alter agreement" } } }, "localname": "DRIPPeriodofNoticetoAlterAgreement", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "durationItemType" }, "hct_DayPriortoCommencementQuarterMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Day Prior to Commencement Quarter [Member]", "label": "Day Prior to Commencement Quarter [Member] [Member]", "terseLabel": "Day Prior to Commencement Quarter" } } }, "localname": "DayPriortoCommencementQuarterMemberMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_DebtCovenantPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Covenant Period [Axis]", "label": "Debt Covenant Period [Axis]", "terseLabel": "Debt Covenant Period [Axis]" } } }, "localname": "DebtCovenantPeriodAxis", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "hct_DebtCovenantPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Debt Covenant Period [Axis]", "label": "Debt Covenant Period [Domain]", "terseLabel": "Debt Covenant Period [Domain]" } } }, "localname": "DebtCovenantPeriodDomain", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_DebtInstrumentCovenantsCurrentBorrowingCapacityBasePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenants, Current Borrowing Capacity Base Percent", "label": "Debt Instrument, Covenants, Current Borrowing Capacity Base Percent", "terseLabel": "Line of credit facility, current borrowing capacity base percent" } } }, "localname": "DebtInstrumentCovenantsCurrentBorrowingCapacityBasePercent", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "hct_DebtInstrumentCovenantsDistributionInExcessOfModifiedFundsFromOperationsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term Debt, Covenant Requirements, Distribution In Excess Of Modified Funds From Operations, Percent", "label": "Debt Instrument, Covenants, Distribution In Excess Of Modified Funds From Operations, Percent", "terseLabel": "Long-term debt, covenant requirements, distribution in excess of modified funds from operations, percent" } } }, "localname": "DebtInstrumentCovenantsDistributionInExcessOfModifiedFundsFromOperationsPercent", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "hct_DebtInstrumentCovenantsFixedChargeCoverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenants, Fixed Charge Coverage Ratio", "label": "Debt Instrument, Covenants, Fixed Charge Coverage Ratio", "terseLabel": "Fixed charge coverage ratio" } } }, "localname": "DebtInstrumentCovenantsFixedChargeCoverageRatio", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "hct_DebtInstrumentCovenantsMinimumCashCashEquivalentsandBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenants, Minimum Cash, Cash Equivalents, and Borrowing Capacity", "label": "Debt Instrument, Covenants, Minimum Cash, Cash Equivalents, and Borrowing Capacity", "terseLabel": "Long-term debt, covenant requirements, amount" } } }, "localname": "DebtInstrumentCovenantsMinimumCashCashEquivalentsandBorrowingCapacity", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "hct_DebtInstrumentCovenantsPercentOfNetOfferingProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenants, Percent Of Net Offering Proceeds", "label": "Debt Instrument, Covenants, Percent Of Net Offering Proceeds", "terseLabel": "Debt instrument, covenants, percent of net offering proceeds" } } }, "localname": "DebtInstrumentCovenantsPercentOfNetOfferingProceeds", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "hct_DebtInstrumentFloorInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Floor Interest Rate", "label": "Debt Instrument, Floor Interest Rate", "terseLabel": "Debt instrument, LIBOR floor interest rate" } } }, "localname": "DebtInstrumentFloorInterestRate", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "hct_DepreciationandAmortizationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Depreciation and Amortization Expense [Member]", "label": "Depreciation and Amortization Expense [Member]", "terseLabel": "Depreciation and Amortization Expense" } } }, "localname": "DepreciationandAmortizationExpenseMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails" ], "xbrltype": "domainItemType" }, "hct_DerivativeNotionalAmountNotYetInEffect": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Derivative, Notional Amount, Not Yet In Effect", "label": "Derivative, Notional Amount, Not Yet In Effect", "terseLabel": "Notional amount of interest rate caps excluded" } } }, "localname": "DerivativeNotionalAmountNotYetInEffect", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "hct_DerivativeNumberofInstrumentsTerminated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Number of Instruments Terminated", "label": "Derivative, Number of Instruments Terminated", "terseLabel": "Number of instruments terminated" } } }, "localname": "DerivativeNumberofInstrumentsTerminated", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "hct_DisposalGroupHeldforuseNotDiscontinuedOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Held-for-use, Not Discontinued Operations [Member]", "label": "Disposal Group, Held-for-use, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Held-for-use, Not Discontinued Operations", "verboseLabel": "Assets held for use" } } }, "localname": "DisposalGroupHeldforuseNotDiscontinuedOperationsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetImpairmentsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_DisposalGroupIncludingDiscontinuedOperationNumberOfPropertiesHeldForSale": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group Including Discontinued Operation, Number Of Properties Held For Sale", "label": "Disposal Group Including Discontinued Operation, Number Of Properties Held For Sale", "terseLabel": "Number of properties held for sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationNumberOfPropertiesHeldForSale", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "integerItemType" }, "hct_DisposalGroupIncludingDiscontinuedOperationNumberOfPropertiesHeldForUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group Including Discontinued Operation, Number Of Properties Held For Use", "label": "Disposal Group Including Discontinued Operation, Number Of Properties Held For Use", "terseLabel": "Number of properties held for use" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationNumberOfPropertiesHeldForUse", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "hct_EarningsPerShareBasicAndDilutedByCommonClassIncludingTwoClassMethodLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]", "label": "Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareBasicAndDilutedByCommonClassIncludingTwoClassMethodLineItems", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "hct_EconomicDependencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Economic Dependency [Abstract]", "label": "Economic Dependency [Abstract]", "terseLabel": "Economic Dependency [Abstract]" } } }, "localname": "EconomicDependencyAbstract", "nsuri": "http://www.thehealthcarereit2.com/20220331", "xbrltype": "stringItemType" }, "hct_EconomicDependencyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Matters related to services provided by affiliate.", "label": "Economic Dependency [Text Block]", "terseLabel": "Economic Dependency" } } }, "localname": "EconomicDependencyTextBlock", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/EconomicDependency" ], "xbrltype": "textBlockItemType" }, "hct_ExcessOfAdjustedMarketValueOfRealEstateAssetsPlusDistributionsOverAggregateContributedInvestorCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Excess of Adjusted Market Value of Real Estate Assets Plus Distributions Over Aggregate Contributed Investor Capital [Member]", "label": "Excess of Adjusted Market Value of Real Estate Assets Plus Distributions Over Aggregate Contributed Investor Capital [Member]", "terseLabel": "Excess of Adjusted Market Value of Real Estate Assets Plus Distributions Over Aggregate Contributed Investor Capital" } } }, "localname": "ExcessOfAdjustedMarketValueOfRealEstateAssetsPlusDistributionsOverAggregateContributedInvestorCapitalMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_FannieCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fannie Credit Facility [Member]", "label": "Fannie Credit Facility [Member]", "terseLabel": "Fannie Credit Facility" } } }, "localname": "FannieCreditFacilityMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "domainItemType" }, "hct_FinanceLeaseLiabilitytobePaidDueafterYearFour": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Liability, to be Paid, Due after Year Four", "label": "Finance Lease, Liability, to be Paid, Due after Year Four", "terseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilitytobePaidDueafterYearFour", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "hct_FoxRidgeSeniorLivingatBryantBryantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fox Ridge Senior Living at Bryant - Bryant [Member]", "label": "Fox Ridge Senior Living at Bryant - Bryant [Member]", "terseLabel": "Fox Ridge Bryant - Bryant, AR" } } }, "localname": "FoxRidgeSeniorLivingatBryantBryantMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "hct_FoxRidgeSeniorLivingatChenalLittleRockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fox Ridge Senior Living at Chenal - Little Rock [Member]", "label": "Fox Ridge Senior Living at Chenal - Little Rock [Member]", "terseLabel": "Fox Ridge Chenal - Little Rock, AR" } } }, "localname": "FoxRidgeSeniorLivingatChenalLittleRockMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "hct_FoxRidgeSeniorLivingatParkstoneNorthLittleRockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fox Ridge Senior Living at Parkstone - North Little Rock [Member]", "label": "Fox Ridge Senior Living at Parkstone - North Little Rock [Member]", "terseLabel": "Fox Ridge North Little Rock - North Little Rock, AR" } } }, "localname": "FoxRidgeSeniorLivingatParkstoneNorthLittleRockMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "hct_GrossRevenueExcludingStandAloneSingleTenantNetLeasedPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross Revenue, Excluding Stand-alone Single-tenant Net Leased Properties [Member]", "label": "Gross Revenue, Excluding Stand-alone Single-tenant Net Leased Properties [Member]", "terseLabel": "Gross Revenue, Excluding Stand-alone Single-tenant Net Leased Properties" } } }, "localname": "GrossRevenueExcludingStandAloneSingleTenantNetLeasedPropertiesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_GrossRevenueManagedPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross Revenue, Managed Properties [Member]", "label": "Gross Revenue, Managed Properties [Member]", "terseLabel": "Gross Revenue, Managed Properties" } } }, "localname": "GrossRevenueManagedPropertiesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_GrossRevenueStandAloneSingleTenantNetLeasedPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross Revenue, Stand-alone Single-tenant Net Leased Properties [Member]", "label": "Gross Revenue, Stand-alone Single-tenant Net Leased Properties [Member]", "terseLabel": "Gross Revenue, Stand-alone Single-tenant Net Leased Properties" } } }, "localname": "GrossRevenueStandAloneSingleTenantNetLeasedPropertiesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_HealthcareTrustOperatingPartnershipL.P.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare Trust Operating Partnership, L.P. [Member]", "label": "Healthcare Trust Operating Partnership, L.P. [Member]", "terseLabel": "Healthcare Trust Operating Partnership, L.P." } } }, "localname": "HealthcareTrustOperatingPartnershipL.P.Member", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "domainItemType" }, "hct_HealthcareTrustSpecialLimitedPartnershipLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare Trust Special Limited Partnership, LLC [Member]", "label": "Healthcare Trust Special Limited Partnership, LLC [Member]", "terseLabel": "Healthcare Trust Special Limited Partnership, LLC" } } }, "localname": "HealthcareTrustSpecialLimitedPartnershipLLCMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_InplaceLeasesandOtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In-place Leases and Other Intangible Assets [Member]", "label": "In-place Leases and Other Intangible Assets [Member]", "terseLabel": "In-place Leases and Other Intangible Assets" } } }, "localname": "InplaceLeasesandOtherIntangibleAssetsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails" ], "xbrltype": "domainItemType" }, "hct_KeyBankFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "KeyBank Facility [Member]", "label": "KeyBank Facility [Member]", "terseLabel": "KeyBank Facility" } } }, "localname": "KeyBankFacilityMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "hct_LaSallePropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LaSalle Properties", "label": "LaSalle Properties [Member]", "terseLabel": "LaSalle Properties" } } }, "localname": "LaSallePropertiesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_LeaseIntangiblesLeaseupPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Intangibles, Lease-up Period", "label": "Lease Intangibles, Lease-up Period", "terseLabel": "Lease intangibles, lease-up period" } } }, "localname": "LeaseIntangiblesLeaseupPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "hct_LeaseRemainingLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease, Remaining Lease Term", "label": "Lease, Remaining Lease Term", "terseLabel": "Remaining lease term" } } }, "localname": "LeaseRemainingLeaseTerm", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "hct_LesseeFinanceLeaseNumberOfContracts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Finance Lease, Number Of Contracts", "label": "Lessee, Finance Lease, Number Of Contracts", "terseLabel": "Number of finance lease contracts" } } }, "localname": "LesseeFinanceLeaseNumberOfContracts", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "hct_LesseeLeaseRenewalTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Lease, Renewal Term", "label": "Lessee, Lease, Renewal Term", "terseLabel": "Renewal term" } } }, "localname": "LesseeLeaseRenewalTerm", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "hct_LesseeOperatingLeaseLiabilitytobePaidDueafterYearFour": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Liability, to be Paid, Due after Year Four", "label": "Lessee, Operating Lease, Liability, to be Paid, Due after Year Four", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilitytobePaidDueafterYearFour", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "hct_LesseeOperatingLeaseNumberOfContracts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Number Of Contracts", "label": "Lessee, Operating Lease, Number Of Contracts", "terseLabel": "Number of operating lease contracts" } } }, "localname": "LesseeOperatingLeaseNumberOfContracts", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "hct_LesseeOperatingLeaseRenewalTermExcluded": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Renewal Term, Excluded", "label": "Lessee, Operating Lease, Renewal Term, Excluded", "terseLabel": "Renewal term of lease excluded" } } }, "localname": "LesseeOperatingLeaseRenewalTermExcluded", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "hct_LessorOperatingLeasePaymenttobeReceivedafterYearFour": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails": { "order": 6.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessor, Operating Lease, Payment to be Received, after Year Four", "label": "Lessor, Operating Lease, Payment to be Received, after Year Four", "terseLabel": "Thereafter" } } }, "localname": "LessorOperatingLeasePaymenttobeReceivedafterYearFour", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "hct_LimitedPartnersCapitalAccountPotentiallyRedeemableAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Limited Partners' Capital Account, Potentially Redeemable Amount", "label": "Limited Partners' Capital Account, Potentially Redeemable Amount", "terseLabel": "Redeemable amount of shares (in shares)" } } }, "localname": "LimitedPartnersCapitalAccountPotentiallyRedeemableAmount", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "hct_LimitedPartnersCapitalAccountUnitsRedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Limited Partners' Capital Account, Units, Redemption Period", "label": "Limited Partners' Capital Account, Units, Redemption Period", "terseLabel": "Limited partner units, redemption period" } } }, "localname": "LimitedPartnersCapitalAccountUnitsRedemptionPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "durationItemType" }, "hct_LineofCreditFacilityAccordionFeatureIncreaseLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit", "label": "Line of Credit Facility, Accordion Feature, Increase Limit", "terseLabel": "Line of credit, increase" } } }, "localname": "LineofCreditFacilityAccordionFeatureIncreaseLimit", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "hct_LineofCreditFacilityExtensionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Extension Period", "label": "Line of Credit Facility, Extension Period", "terseLabel": "Line of credit facility, extension period" } } }, "localname": "LineofCreditFacilityExtensionPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "hct_LongTermDebtMaturityafterYearFour": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails": { "order": 6.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt, Maturity, after Year Four", "label": "Long-Term Debt, Maturity, after Year Four", "verboseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturityafterYearFour", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails" ], "xbrltype": "monetaryItemType" }, "hct_LongTermLineOfCreditMaturityExtensionTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long Term Line Of Credit, Maturity, Extension Term", "label": "Long Term Line Of Credit, Maturity, Extension Term", "terseLabel": "Maturity extension" } } }, "localname": "LongTermLineOfCreditMaturityExtensionTerm", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "durationItemType" }, "hct_LongtermLineofCreditIncludingFinancingCosts": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term Line of Credit, Including Financing Costs", "label": "Long-term Line of Credit, Including Financing Costs", "totalLabel": "Outstanding balance, net" } } }, "localname": "LongtermLineofCreditIncludingFinancingCosts", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "hct_MOBLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MOB Loan [Member]", "label": "MOB Loan [Member]", "verboseLabel": "Capital One MOB Loan" } } }, "localname": "MOBLoanMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "hct_MasterCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Master Credit Facility [Member]", "label": "Master Credit Facility [Member]", "terseLabel": "Fannie Mae Master Credit Facilities" } } }, "localname": "MasterCreditFacilityMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "hct_MedicalCenterVPeoriaAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical Center V - Peoria, AZ [Member]", "label": "Medical Center V - Peoria, AZ [Member]", "terseLabel": "Medical Center V - Peoria, AZ" } } }, "localname": "MedicalCenterVPeoriaAZMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "hct_MedicalOfficeBuildingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical Office Buildings [Member]", "label": "Medical Office Buildings [Member]", "terseLabel": "Medical office buildings" } } }, "localname": "MedicalOfficeBuildingsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_MonthlyBaseManagementFeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Monthly Base Management Fee [Member]", "label": "Monthly Base Management Fee [Member]", "terseLabel": "Monthly Base Management Fee" } } }, "localname": "MonthlyBaseManagementFeeMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_MultiPropertyCMBSLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-Property CMBS Loan [Member]", "label": "Multi-Property CMBS Loan [Member]", "terseLabel": "Multi-Property CMBS Loan" } } }, "localname": "MultiPropertyCMBSLoanMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "hct_NetSaleProceedsAfterReturnOfCapitalContributionsAndAnnualTargetedInvestorReturnMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Sale Proceeds, after Return of Capital Contributions and Annual Targeted Investor Return [Member]", "label": "Net Sale Proceeds, after Return of Capital Contributions and Annual Targeted Investor Return [Member]", "terseLabel": "Net Sale Proceeds, after Return of Capital Contributions and Annual Targeted Investor Return" } } }, "localname": "NetSaleProceedsAfterReturnOfCapitalContributionsAndAnnualTargetedInvestorReturnMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_NewCreditFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Credit Facilities [Member]", "label": "New Credit Facilities [Member]", "terseLabel": "New Credit Facilities" } } }, "localname": "NewCreditFacilitiesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_NoncontrollingInterestTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncontrolling Interest", "label": "Noncontrolling Interest [Table Text Block]", "terseLabel": "Schedule of Noncontrolling Interest on Balance Sheet" } } }, "localname": "NoncontrollingInterestTableTextBlock", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsTables" ], "xbrltype": "textBlockItemType" }, "hct_NoncontrollingInterestsInPropertyOwningSubsidiaries": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails": { "order": 2.0, "parentTag": "us-gaap_MinorityInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncontrolling Interests In Property Owning Subsidiaries", "label": "Noncontrolling Interests In Property Owning Subsidiaries", "terseLabel": "Non-controlling Interests in property owning subsidiaries" } } }, "localname": "NoncontrollingInterestsInPropertyOwningSubsidiaries", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails" ], "xbrltype": "monetaryItemType" }, "hct_NumberOfIndependentContractors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Independent Contractors", "label": "Number Of Independent Contractors", "terseLabel": "Number of independent contractors" } } }, "localname": "NumberOfIndependentContractors", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails" ], "xbrltype": "integerItemType" }, "hct_NumberOfInterestRateDerivativesNotYetInEffect": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Interest Rate Derivatives Not Yet In Effect", "label": "Number Of Interest Rate Derivatives Not Yet In Effect", "terseLabel": "Interest rate cap agreements excluded" } } }, "localname": "NumberOfInterestRateDerivativesNotYetInEffect", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "integerItemType" }, "hct_NumberOfLandParcels": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Land Parcels", "label": "Number Of Land Parcels", "terseLabel": "Number of land parcels" } } }, "localname": "NumberOfLandParcels", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails" ], "xbrltype": "integerItemType" }, "hct_NumberOfRealEstatePropertiesEncumbered": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Real Estate Properties, Encumbered", "label": "Number of Real Estate Properties, Encumbered", "terseLabel": "Encumbered Properties" } } }, "localname": "NumberOfRealEstatePropertiesEncumbered", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "integerItemType" }, "hct_NumberofSeniorHousingCommunities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Senior Housing Communities", "label": "Number of Senior Housing Communities", "terseLabel": "Number of senior housing communities" } } }, "localname": "NumberofSeniorHousingCommunities", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "hct_OpUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OP Units [Member]", "label": "OP Units [Member]", "terseLabel": "OP Units", "verboseLabel": "Common OP Units" } } }, "localname": "OpUnitsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Income (Loss) Before Gain (Loss) on Sale of Real Estate Investments", "label": "Operating Income (Loss) Before Gain (Loss) on Sale of Real Estate Investments", "totalLabel": "Operating income (loss) before gain on sale of real estate investments" } } }, "localname": "OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "hct_OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Net Investment in Lease, Credit Loss Expense (Reversal)", "label": "Operating Lease, Net Investment in Lease, Credit Loss Expense (Reversal)", "terseLabel": "Bad debt expense" } } }, "localname": "OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "hct_OperationFeesAndReimbursementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operation Fees and Reimbursements [Member]", "label": "Operation Fees and Reimbursements [Member]", "terseLabel": "Total related party operation fees and reimbursements" } } }, "localname": "OperationFeesAndReimbursementsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_PalmValleyMedicalPlazaAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Palm Valley Medical Plaza AZ [Member]", "label": "Palm Valley Medical Plaza AZ [Member]", "terseLabel": "Palm Valley Medical Plaza - Goodyear, AZ (4)" } } }, "localname": "PalmValleyMedicalPlazaAZMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "hct_PaymentForPurchaseofInterestRateCashFlowHedge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment For Purchase of Interest Rate Cash Flow Hedge", "label": "Payment For Purchase of Interest Rate Cash Flow Hedge", "terseLabel": "Payment for purchase of interest rate cap contract" } } }, "localname": "PaymentForPurchaseofInterestRateCashFlowHedge", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "hct_PlazaDelRioMedicalOfficeCampusPortfolioAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plaza Del Rio Medical Office Campus Portfolio AZ [Member]", "label": "Plaza Del Rio Medical Office Campus Portfolio AZ [Member]", "terseLabel": "Plaza Del Rio Medical Office Campus Portfolio - Peoria, AZ" } } }, "localname": "PlazaDelRioMedicalOfficeCampusPortfolioAZMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "domainItemType" }, "hct_PreTaxNonCompoundedReturnOnCapitalContributionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-tax Non-compounded Return on Capital Contribution [Member]", "label": "Pre-tax Non-compounded Return on Capital Contribution [Member]", "terseLabel": "Pre-tax Non-compounded Return on Capital Contribution" } } }, "localname": "PreTaxNonCompoundedReturnOnCapitalContributionMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_PreferredStockAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stock, Additional Shares Authorized", "label": "Preferred Stock, Additional Shares Authorized", "terseLabel": "Preferred stock, additional shares authorized (in shares)" } } }, "localname": "PreferredStockAdditionalSharesAuthorized", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "hct_PreferredUnitFaceValueSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Unit, Face Value, Share Price", "label": "Preferred Unit, Face Value, Share Price", "terseLabel": "Preferred unit, face value (in usd per share)" } } }, "localname": "PreferredUnitFaceValueSharePrice", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "hct_PreferredUnitIssuanceValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Preferred Unit, Issuance Value", "label": "Preferred Unit, Issuance Value", "terseLabel": "Value of preferred OP Units" } } }, "localname": "PreferredUnitIssuanceValue", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "monetaryItemType" }, "hct_PreferredUnitIssuanceValueSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Unit, Issuance Value, Share Price", "label": "Preferred Unit, Issuance Value, Share Price", "terseLabel": "Preferred units issued (in usd per share)" } } }, "localname": "PreferredUnitIssuanceValueSharePrice", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "hct_PreferredUnitsRedemptionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Units, Redemption Period", "label": "Preferred Units, Redemption Period", "terseLabel": "Preferred units, redemption period" } } }, "localname": "PreferredUnitsRedemptionPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "durationItemType" }, "hct_PrepaidExpensesAndOtherAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prepaid Expenses And Other Assets", "label": "Prepaid Expenses And Other Assets [Member]", "terseLabel": "Prepaid Expenses And Other Assets" } } }, "localname": "PrepaidExpensesAndOtherAssetsMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_ProceedsFromGovernmentAssistanceCARESAct": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Government Assistance, CARES Act", "label": "Proceeds From Government Assistance, CARES Act", "terseLabel": "Additional CARES Act funding" } } }, "localname": "ProceedsFromGovernmentAssistanceCARESAct", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "hct_ProceedsFromRelatedPartyAccountsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Related Party, Accounts Receivable", "label": "Proceeds From Related Party, Accounts Receivable", "terseLabel": "Amounts received" } } }, "localname": "ProceedsFromRelatedPartyAccountsReceivable", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "hct_ProceedsFromSaleofInterestRateCashFlowHedge": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Sale of Interest Rate Cash Flow Hedge", "label": "Proceeds From Sale of Interest Rate Cash Flow Hedge", "terseLabel": "Proceeds from sale of interest rate cash flow hedge" } } }, "localname": "ProceedsFromSaleofInterestRateCashFlowHedge", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "hct_ProfessionalFeesCreditDueFromAdvisorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Professional Fees Credit Due From Advisor", "label": "Professional Fees Credit Due From Advisor [Member]", "terseLabel": "Professional fees credit due from Advisor" } } }, "localname": "ProfessionalFeesCreditDueFromAdvisorMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_PropertyManagementAndLeasingFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property Management and Leasing Fees [Member]", "label": "Property Management and Leasing Fees [Member]", "terseLabel": "Property Management and Leasing Fees" } } }, "localname": "PropertyManagementAndLeasingFeesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_PropertyManagementFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property Management Fees [Member]", "label": "Property Management Fees [Member]", "terseLabel": "Property management and fees" } } }, "localname": "PropertyManagementFeesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_PropertyOperatingandMaintenanceExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property Operating and Maintenance Expense [Member]", "label": "Property Operating and Maintenance Expense [Member]", "terseLabel": "Property Operating and Maintenance Expense" } } }, "localname": "PropertyOperatingandMaintenanceExpenseMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails" ], "xbrltype": "domainItemType" }, "hct_PublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Offering", "label": "Public Offering [Member]", "terseLabel": "Public Offering" } } }, "localname": "PublicOfferingMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "hct_PublicStockOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Stock Offering [Member]", "label": "Public Stock Offering [Member]", "terseLabel": "Public Stock Offering" } } }, "localname": "PublicStockOfferingMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "hct_PurchasePriceAllocationPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase Price Allocation Policy [Policy Text Block]", "label": "Purchase Price Allocation Policy [Policy Text Block]", "terseLabel": "Purchase Price Allocation" } } }, "localname": "PurchasePriceAllocationPolicyPolicyTextBlock", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "hct_QuarterlyVariableManagementFeeBenchmarkOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quarterly Variable Management Fee, Benchmark One [Member]", "label": "Quarterly Variable Management Fee, Benchmark One [Member]", "terseLabel": "Quarterly Variable Management Fee, Benchmark One" } } }, "localname": "QuarterlyVariableManagementFeeBenchmarkOneMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_QuarterlyVariableManagementFeeBenchmarkTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quarterly Variable Management Fee, Benchmark Two [Member]", "label": "Quarterly Variable Management Fee, Benchmark Two [Member]", "terseLabel": "Quarterly Variable Management Fee, Benchmark Two" } } }, "localname": "QuarterlyVariableManagementFeeBenchmarkTwoMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_RealEstateCostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate Cost [Member]", "label": "Real Estate Cost [Member]", "terseLabel": "Real Estate Cost" } } }, "localname": "RealEstateCostMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_RealEstateInvestmentAtCostRelatingtoNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real Estate Investment, At Cost Relating to Notes Payable", "label": "Real Estate Investment, At Cost Relating to Notes Payable", "terseLabel": "Real estate investment, at cost relating to notes payable" } } }, "localname": "RealEstateInvestmentAtCostRelatingtoNotesPayable", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "hct_ReimbursementsofAdministrativeServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reimbursements of Administrative Services [Member]", "label": "Reimbursements of Administrative Services [Member]", "terseLabel": "Reimbursements of Administrative Services" } } }, "localname": "ReimbursementsofAdministrativeServicesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_RelatedPartyAgreementTermofAgreementRenewalPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Agreement, Term of Agreement, Renewal Period", "label": "Related Party Agreement, Term of Agreement, Renewal Period", "terseLabel": "Renewal period" } } }, "localname": "RelatedPartyAgreementTermofAgreementRenewalPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "durationItemType" }, "hct_RelatedPartyFeesBenchmarkDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Fees, Benchmark [Domain]", "label": "Related Party Fees, Benchmark [Domain]", "terseLabel": "Related Party Fees, Benchmark [Domain]" } } }, "localname": "RelatedPartyFeesBenchmarkDomain", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_RelatedPartyFeesByBenchmarkAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Fees, by Benchmark [Axis]", "label": "Related Party Fees, by Benchmark [Axis]", "terseLabel": "Related Party Fees, by Benchmark [Axis]" } } }, "localname": "RelatedPartyFeesByBenchmarkAxis", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "stringItemType" }, "hct_RelatedPartyTransactionAssetThresholdQualifyingManagement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Asset Threshold Qualifying Management", "label": "Related Party Transaction, Asset Threshold Qualifying Management", "terseLabel": "Assets under management threshold" } } }, "localname": "RelatedPartyTransactionAssetThresholdQualifyingManagement", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "hct_RelatedPartyTransactionBaseManagementFeeofNetProceedsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Base Management Fee of Net Proceeds, Percent", "label": "Related Party Transaction, Base Management Fee of Net Proceeds, Percent", "terseLabel": "Base management fee of net proceeds" } } }, "localname": "RelatedPartyTransactionBaseManagementFeeofNetProceedsPercent", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionBasisCostOfLivingPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction Basis Cost Of Living Percent", "label": "Related Party Transaction Basis Cost Of Living Percent", "terseLabel": "Cost of living percent multiplier" } } }, "localname": "RelatedPartyTransactionBasisCostOfLivingPercent", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "pureItemType" }, "hct_RelatedPartyTransactionBasisofCoreEarningsPerShareBasis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Basis of Core Earnings, Per Share Basis", "label": "Related Party Transaction, Basis of Core Earnings, Per Share Basis", "terseLabel": "Basis of core earnings, share basis (in usd per share)" } } }, "localname": "RelatedPartyTransactionBasisofCoreEarningsPerShareBasis", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "perShareItemType" }, "hct_RelatedPartyTransactionBasisofCoreEarningsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Basis of Core Earnings, Percent", "label": "Related Party Transaction, Basis of Core Earnings, Percent", "terseLabel": "Basis of core earnings, percent" } } }, "localname": "RelatedPartyTransactionBasisofCoreEarningsPercent", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionBasisofRealEstateCostPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction Basis of Real Estate Cost Percent", "label": "Related Party Transaction Basis of Real Estate Cost Percent", "terseLabel": "Real estate cost percent multiplier" } } }, "localname": "RelatedPartyTransactionBasisofRealEstateCostPercent", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "pureItemType" }, "hct_RelatedPartyTransactionContingentGoodFaithNegotiationsOfFixedComponentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Contingent Good Faith Negotiations Of Fixed Component, Term", "label": "Related Party Transaction, Contingent Good Faith Negotiations Of Fixed Component, Term", "terseLabel": "Contingent good faith negotiations of fixed component, term" } } }, "localname": "RelatedPartyTransactionContingentGoodFaithNegotiationsOfFixedComponentTerm", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "durationItemType" }, "hct_RelatedPartyTransactionCumulativeCapitalInvestmentReturnAsPercentageOfBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Cumulative Capital Investment Return, as a Percentage of Benchmark", "label": "Related Party Transaction, Cumulative Capital Investment Return, as a Percentage of Benchmark", "terseLabel": "Cumulative capital investment return to investors as a percentage of benchmark" } } }, "localname": "RelatedPartyTransactionCumulativeCapitalInvestmentReturnAsPercentageOfBenchmark", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionDistributionUponNonrenewalOfAdvisoryAgreementPercentageOfBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Distribution Upon Nonrenewal of Advisory Agreement, Percentage of Benchmark", "label": "Related Party Transaction, Distribution Upon Nonrenewal of Advisory Agreement, Percentage of Benchmark", "terseLabel": "Distribution upon nonrenewal of advisory agreement" } } }, "localname": "RelatedPartyTransactionDistributionUponNonrenewalOfAdvisoryAgreementPercentageOfBenchmark", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionFeeMultiplier": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Fee Multiplier", "label": "Related Party Transaction, Fee Multiplier", "terseLabel": "Fee multiplier" } } }, "localname": "RelatedPartyTransactionFeeMultiplier", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "pureItemType" }, "hct_RelatedPartyTransactionFeePaymentPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Fee Payment Period", "label": "Related Party Transaction, Fee Payment Period", "terseLabel": "Fee payment period" } } }, "localname": "RelatedPartyTransactionFeePaymentPeriod", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "durationItemType" }, "hct_RelatedPartyTransactionOversightFeesEarnedByRelatedPartyPercentageOfBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Oversight Fees Earned by Related Party, Percentage of Benchmark", "label": "Related Party Transaction, Oversight Fees Earned by Related Party, Percentage of Benchmark", "terseLabel": "Oversight fees earned by related party" } } }, "localname": "RelatedPartyTransactionOversightFeesEarnedByRelatedPartyPercentageOfBenchmark", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionPeriodofNoticeforTermination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Period of Notice for Termination", "label": "Related Party Transaction, Period of Notice for Termination", "terseLabel": "Period of notice of termination" } } }, "localname": "RelatedPartyTransactionPeriodofNoticeforTermination", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "durationItemType" }, "hct_RelatedPartyTransactionPeriodofNoticetoAlterAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Period of Notice to Alter Agreement", "label": "Related Party Transaction, Period of Notice to Alter Agreement", "terseLabel": "Period to terminate early with board approval" } } }, "localname": "RelatedPartyTransactionPeriodofNoticetoAlterAgreement", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "durationItemType" }, "hct_RelatedPartyTransactionPropertyManagementFeesEarnedByRelatedPartyPercentageOfBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Property Management Fees Earned by Related Party, Percentage of Benchmark", "label": "Related Party Transaction, Property Management Fees Earned by Related Party, Percentage of Benchmark", "terseLabel": "Property management fees" } } }, "localname": "RelatedPartyTransactionPropertyManagementFeesEarnedByRelatedPartyPercentageOfBenchmark", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionQuarterlyAssetManagementFeeEarnedByRelatedPartyPercentageOfBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Quarterly Asset Management Fee Earned By Related Party, Percentage of Benchmark", "label": "Related Party Transaction, Quarterly Asset Management Fee Earned By Related Party, Percentage of Benchmark", "terseLabel": "Quarterly asset management earned by related party, percentage of benchmark" } } }, "localname": "RelatedPartyTransactionQuarterlyAssetManagementFeeEarnedByRelatedPartyPercentageOfBenchmark", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionReductionofRealEstateCostPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction Reduction of Real Estate Cost Percent", "label": "Related Party Transaction Reduction of Real Estate Cost Percent", "terseLabel": "Reduction of real estate cost percent" } } }, "localname": "RelatedPartyTransactionReductionofRealEstateCostPercent", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "pureItemType" }, "hct_RelatedPartyTransactionReimbursedFeestoRelatedPartyCappedReimbursementAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Reimbursed Fees to Related Party, Capped Reimbursement Amount", "label": "Related Party Transaction, Reimbursed Fees to Related Party, Capped Reimbursement Amount", "terseLabel": "Fixed component" } } }, "localname": "RelatedPartyTransactionReimbursedFeestoRelatedPartyCappedReimbursementAmount", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "monetaryItemType" }, "hct_RelatedPartyTransactionReimbursedFeestoRelatedPartyPercentageofBenchmarkExpectedCompanysPortfolioCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Reimbursed Fees to Related Party, Percentage of Benchmark, Expected Company's Portfolio Costs", "label": "Related Party Transaction, Reimbursed Fees to Related Party, Percentage of Benchmark, Expected Company's Portfolio Costs", "terseLabel": "Financing advance fees as a percentage of benchmark, expected company portfolio cost" } } }, "localname": "RelatedPartyTransactionReimbursedFeestoRelatedPartyPercentageofBenchmarkExpectedCompanysPortfolioCosts", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionReimbursedFeestoRelatedPartyPercentageofBenchmarkExpectedThirdPartyAcquisitionCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Reimbursed Fees to Related Party, Percentage of Benchmark, Expected Third Party Acquisition Costs", "label": "Related Party Transaction, Reimbursed Fees to Related Party, Percentage of Benchmark, Expected Third Party Acquisition Costs", "terseLabel": "Reimbursed fees to related party, percentage of benchmark" } } }, "localname": "RelatedPartyTransactionReimbursedFeestoRelatedPartyPercentageofBenchmarkExpectedThirdPartyAcquisitionCosts", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionSpecialAllocationforTaxPurposesExcessDepreciationDeductionsMaximum": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Special Allocation for Tax Purposes, Excess Depreciation Deductions Maximum", "label": "Related Party Transaction, Special Allocation for Tax Purposes, Excess Depreciation Deductions Maximum", "terseLabel": "Excess depreciation deductions maximum" } } }, "localname": "RelatedPartyTransactionSpecialAllocationforTaxPurposesExcessDepreciationDeductionsMaximum", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "hct_RelatedPartyTransactionSubordinatedIncentiveListingDistributionPercentageOfBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Subordinated Incentive Listing Distribution, Percentage of Benchmark", "label": "Related Party Transaction, Subordinated Incentive Listing Distribution, Percentage of Benchmark", "terseLabel": "Subordinated incentive listing distribution" } } }, "localname": "RelatedPartyTransactionSubordinatedIncentiveListingDistributionPercentageOfBenchmark", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionSubordinatedPerformanceFeeEarnedByRelatedPartyPercentageOfBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Subordinated Performance Fee Earned by Related Party, Percentage of Benchmark", "label": "Related Party Transaction, Subordinated Performance Fee Earned by Related Party, Percentage of Benchmark", "terseLabel": "Subordinated performance fee as a percentage of benchmark" } } }, "localname": "RelatedPartyTransactionSubordinatedPerformanceFeeEarnedByRelatedPartyPercentageOfBenchmark", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "percentItemType" }, "hct_RelatedPartyTransactionTermofAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Term of Agreement", "label": "Related Party Transaction, Term of Agreement", "terseLabel": "Related party term of agreement" } } }, "localname": "RelatedPartyTransactionTermofAgreement", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "durationItemType" }, "hct_RelatedPartyTransactionVotingPercentageRequiredtoAlterAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Voting Percentage Required to Alter Agreement", "label": "Related Party Transaction, Voting Percentage Required to Alter Agreement", "terseLabel": "Percent of board approval required for early termination" } } }, "localname": "RelatedPartyTransactionVotingPercentageRequiredtoAlterAgreement", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "percentItemType" }, "hct_RentCollectionPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rent Collection Percentage", "label": "Rent Collection Percentage", "terseLabel": "Rent collections percent" } } }, "localname": "RentCollectionPercentage", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "hct_RentalIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rental Income [Member]", "label": "Rental Income [Member]", "terseLabel": "Rental Income" } } }, "localname": "RentalIncomeMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "hct_RestrictedSharePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Share Plan [Member]", "label": "Restricted Share Plan [Member]", "terseLabel": "Restricted Share Plan" } } }, "localname": "RestrictedSharePlanMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "hct_SaleOfStockConsiderationReceivedOnTransactionGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sale of Stock, Consideration Received on Transaction, Gross", "label": "Sale of Stock, Consideration Received on Transaction, Gross", "terseLabel": "Gross proceeds" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransactionGross", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "monetaryItemType" }, "hct_SaleOfStockDiscountOnOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Discount On Offering", "label": "Sale Of Stock, Discount On Offering", "terseLabel": "Underwriters discount on offering" } } }, "localname": "SaleOfStockDiscountOnOffering", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "monetaryItemType" }, "hct_ScheduleOfAmountContractuallyDueAndForgivenInConnectionWithOperationRelatedServicesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Amount Contractually Due and Forgiven in Connection With Operation Related Services [Table Text Block]", "label": "Schedule of Amount Contractually Due and Forgiven in Connection With Operation Related Services [Table Text Block]", "terseLabel": "Schedule of Amount Contractually Due and Forgiven in Connection With Operation Related Services" } } }, "localname": "ScheduleOfAmountContractuallyDueAndForgivenInConnectionWithOperationRelatedServicesTableTextBlock", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsTables" ], "xbrltype": "textBlockItemType" }, "hct_ScheduleOfEarningsPerShareBasicAndDilutedByCommonClassIncludingTwoClassMethodTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Table]", "label": "Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Table]", "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedByCommonClassIncludingTwoClassMethodTable", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "hct_SecondAmendedandRestatedAdvisoryAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Amended and Restated Advisory Agreement [Member]", "label": "Second Amended and Restated Advisory Agreement [Member]", "terseLabel": "Second Amended and Restated Advisory Agreement" } } }, "localname": "SecondAmendedandRestatedAdvisoryAgreementMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_SeniorsHousingCommunitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seniors Housing Communities [Member]", "label": "Seniors Housing Communities [Member]", "terseLabel": "Seniors Housing Communities", "verboseLabel": "Seniors housing - operating properties" } } }, "localname": "SeniorsHousingCommunitiesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_SeriesACumulativeRedeemablePerpetualPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A Cumulative Redeemable Perpetual Preferred Stock", "label": "Series A Cumulative Redeemable Perpetual Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock" } } }, "localname": "SeriesACumulativeRedeemablePerpetualPreferredStockMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical", "http://www.thehealthcarereit2.com/role/CoverPage", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "hct_SeriesAPreferredUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A Preferred Unit", "label": "Series A Preferred Unit [Member]", "terseLabel": "Series A Preferred Unit" } } }, "localname": "SeriesAPreferredUnitMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails" ], "xbrltype": "domainItemType" }, "hct_SeriesBCumulativeRedeemablePerpetualPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B Cumulative Redeemable Perpetual Preferred Stock", "label": "Series B Cumulative Redeemable Perpetual Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock" } } }, "localname": "SeriesBCumulativeRedeemablePerpetualPreferredStockMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical", "http://www.thehealthcarereit2.com/role/CoverPage", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "hct_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsStockDividend": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Stock Dividend", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Stock Dividend", "terseLabel": "Stock dividend (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsStockDividend", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "sharesItemType" }, "hct_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsStockDividendWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Stock Dividend, Weighted Average Grant Date Fair Value", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Stock Dividend, Weighted Average Grant Date Fair Value", "terseLabel": "Stock dividend (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsStockDividendWeightedAverageGrantDateFairValue", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "perShareItemType" }, "hct_SharePriceEquityInstrumentsNetofSellingCommissionsandDealerFees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Price, Equity Instruments, Net of Selling Commissions and Dealer Fees", "label": "Share Price, Equity Instruments, Net of Selling Commissions and Dealer Fees", "terseLabel": "Equity instruments, net of selling commissions (in usd per share)" } } }, "localname": "SharePriceEquityInstrumentsNetofSellingCommissionsandDealerFees", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "perShareItemType" }, "hct_ShilohIllinoisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shiloh - Illinois [Member]", "label": "Shiloh - Illinois [Member]", "terseLabel": "Shiloh - Illinois" } } }, "localname": "ShilohIllinoisMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "hct_SpecialLimitedPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Special Limited Partner [Member]", "label": "Special Limited Partner [Member]", "terseLabel": "Special Limited Partner" } } }, "localname": "SpecialLimitedPartnerMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_SubjectFeesTransitionFeeNotinExcessoftheProductMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subject Fees (Transition Fee Not in Excess of the Product) [Member]", "label": "Subject Fees (Transition Fee Not in Excess of the Product) [Member]", "terseLabel": "Subject Fees (Transition Fee Not in Excess of the Product)" } } }, "localname": "SubjectFeesTransitionFeeNotinExcessoftheProductMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_TaxDepreciationDeductionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Depreciation Deduction [Member]", "label": "Tax Depreciation Deduction [Member]", "terseLabel": "Tax Depreciation Deduction" } } }, "localname": "TaxDepreciationDeductionMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan [Member]", "label": "Term Loan [Member]", "terseLabel": "Term Loan" } } }, "localname": "TermLoanMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "hct_ThirdAmendedAndRestatedAdvisoryAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Amended And Restated Advisory Agreement [Member]", "label": "Third Amended And Restated Advisory Agreement [Member]", "terseLabel": "Third Amended And Restated Advisory Agreement" } } }, "localname": "ThirdAmendedAndRestatedAdvisoryAgreementMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails" ], "xbrltype": "domainItemType" }, "hct_TransferAgentandOtherProfessionalFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfer Agent and other professional fees [Member]", "label": "Transfer Agent and Other Professional Fees [Member]", "terseLabel": "Professional fees and other reimbursements" } } }, "localname": "TransferAgentandOtherProfessionalFeesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "hct_TransitionFeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transition Fee [Member]", "label": "Transition Fee [Member]", "terseLabel": "Transition Fee" } } }, "localname": "TransitionFeeMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_TripleNetLeasedHealthcareFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Triple-Net Leased Healthcare Facilities [Member]", "label": "Triple-Net Leased Healthcare Facilities [Member]", "terseLabel": "Triple-Net Leased Properties" } } }, "localname": "TripleNetLeasedHealthcareFacilitiesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_UnencumberedPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unencumbered Properties [Member]", "label": "Unencumbered Properties [Member]", "terseLabel": "Unencumbered Properties" } } }, "localname": "UnencumberedPropertiesMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "hct_VariableManagementIncentiveFeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Management - Incentive Fee [Member]", "label": "Variable Management - Incentive Fee [Member]", "terseLabel": "Variable Management - Incentive Fee" } } }, "localname": "VariableManagementIncentiveFeeMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "hct_WellingtonFloridaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wellington, Florida", "label": "Wellington, Florida [Member]", "terseLabel": "Wellington, Florida" } } }, "localname": "WellingtonFloridaMember", "nsuri": "http://www.thehealthcarereit2.com/20220331", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r355", "r508", "r509", "r512", "r618" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r135", "r187", "r200", "r201", "r202", "r203", "r205", "r207", "r211", "r251", "r252", "r253", "r254", "r255", "r256", "r258", "r259", "r261", "r263", "r264" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r135", "r187", "r200", "r201", "r202", "r203", "r205", "r207", "r211", "r251", "r252", "r253", "r254", "r255", "r256", "r258", "r259", "r261", "r263", "r264" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r54", "r57", "r133", "r134", "r270", "r308" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Director" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r269", "r307", "r358", "r360", "r524", "r525", "r526", "r527", "r528", "r529", "r532", "r592", "r594", "r623", "r625" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r269", "r307", "r358", "r360", "r524", "r525", "r526", "r527", "r528", "r529", "r532", "r592", "r594", "r623", "r625" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "auth_ref": [ "r606", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Real Estate, Type of Property [Axis]", "terseLabel": "Real Estate, Type of Property [Axis]" } } }, "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "auth_ref": [ "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Real Estate [Domain]", "terseLabel": "Real Estate [Domain]" } } }, "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r269", "r307", "r347", "r358", "r360", "r524", "r525", "r526", "r527", "r528", "r529", "r532", "r592", "r594", "r623", "r625" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r269", "r307", "r347", "r358", "r360", "r524", "r525", "r526", "r527", "r528", "r529", "r532", "r592", "r594", "r623", "r625" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": { "auth_ref": [ "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r619" ], "lang": { "en-us": { "role": { "label": "Name of Property [Axis]", "terseLabel": "Name of Property [Axis]" } } }, "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": { "auth_ref": [ "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r619" ], "lang": { "en-us": { "role": { "label": "Name of Property [Domain]", "terseLabel": "Name of Property [Domain]" } } }, "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r56", "r57", "r133", "r134", "r270", "r308" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r214", "r215", "r344", "r345", "r593", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r214", "r215", "r344", "r345", "r593", "r606", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r219", "r511" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_FL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FLORIDA", "verboseLabel": "Florida" } } }, "localname": "FL", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "domainItemType" }, "stpr_IA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IOWA", "terseLabel": "Iowa" } } }, "localname": "IA", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "domainItemType" }, "stpr_IL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ILLINOIS", "terseLabel": "Illinois" } } }, "localname": "IL", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_MI": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MICHIGAN", "terseLabel": "Michigan" } } }, "localname": "MI", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_PA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PENNSYLVANIA", "terseLabel": "Pennsylvania" } } }, "localname": "PA", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "domainItemType" }, "stpr_TX": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TEXAS", "terseLabel": "Texas" } } }, "localname": "TX", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AboveMarketLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leases acquired as part of a real property acquisition at above market lease rate.", "label": "Above Market Leases [Member]", "terseLabel": "Above-market lease assets" } } }, "localname": "AboveMarketLeasesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r557", "r579" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.", "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses (including $391 and $47 due to related parties as of March\u00a031, 2022 and December\u00a031, 2021)" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDistributionsInExcessOfNetIncome": { "auth_ref": [ "r601" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount as of the balance sheet date by which cumulative distributions to shareholders (or partners) exceed retained earnings (or accumulated earnings).", "label": "Accumulated Distributions in Excess of Net Income", "negatedTerseLabel": "Distributions in excess of accumulated earnings" } } }, "localname": "AccumulatedDistributionsInExcessOfNetIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r62", "r63", "r64", "r68", "r77", "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]", "terseLabel": "Unrealized Gain(loss) on Designated Derivative" } } }, "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r29", "r66", "r67", "r68", "r574", "r598", "r599" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r77", "r78", "r468", "r469", "r470", "r471", "r472", "r474" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r65", "r68", "r77", "r78", "r79", "r137", "r138", "r139", "r406", "r595", "r596", "r634" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r28", "r379", "r517" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r137", "r138", "r139", "r376", "r377", "r378", "r445" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash\u00a0provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AffiliateCosts": { "auth_ref": [ "r94" ], "calculation": { "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs associated with revenues arising from an entity that is an affiliate of the reporting entity by means of direct or indirect ownership.", "label": "Affiliate Costs", "negatedTerseLabel": "Operating fees to related parties" } } }, "localname": "AffiliateCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r362", "r373", "r380" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Share-based payment arrangement, expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r97", "r113", "r289", "r478" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of mortgage premiums and discounts, net" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r88", "r113", "r289", "r480" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of deferred financing costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r113", "r224", "r229" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of market least intangibles" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AncillaryFeeIncomeGeneratedByServicingFinancialAssetsAmount": { "auth_ref": [ "r531" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "All amounts that are due to the servicer of a financial asset, excluding contractually specified servicing fees and late fees.", "label": "Ancillary Fee Income Generated by Servicing Financial Assets, Amount", "terseLabel": "Ancillary revenue" } } }, "localname": "AncillaryFeeIncomeGeneratedByServicingFinancialAssetsAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfRealEstateProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of a real estate property.", "label": "Area of Real Estate Property", "terseLabel": "Rentable square feet" } } }, "localname": "AreaOfRealEstateProperty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails" ], "xbrltype": "areaItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r113", "r234" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r130", "r195", "r202", "r209", "r221", "r251", "r252", "r253", "r255", "r256", "r257", "r258", "r260", "r262", "r264", "r265", "r400", "r408", "r466", "r515", "r517", "r550", "r570" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNeededForImmediateSettlementAggregateFairValue": { "auth_ref": [ "r436" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate fair value of assets needed to immediately settle the derivative instruments with credit-risk-related contingent features if the credit-risk-related contingent features were triggered at the end of the reporting period.", "label": "Assets Needed for Immediate Settlement, Aggregate Fair Value", "terseLabel": "Aggregate termination value" } } }, "localname": "AssetsNeededForImmediateSettlementAggregateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r2", "r3", "r11", "r13", "r16", "r241" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "Assets held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r364", "r375" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r420", "r425" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BankingRegulationMortgageBankingNetWorthActual": { "auth_ref": [ "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of net worth for mortgage banking as defined by regulatory framework.", "label": "Banking Regulation, Mortgage Banking, Net Worth, Actual", "terseLabel": "Consolidated tangible net worth" } } }, "localname": "BankingRegulationMortgageBankingNetWorthActual", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BelowMarketLeaseAmortizationIncomeNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization income for lease with finite life acquired as part of real property acquisition at below market lease rate expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Below Market Lease, Amortization Income, Year One", "terseLabel": "Below market leases, amortization income, 2023" } } }, "localname": "BelowMarketLeaseAmortizationIncomeNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BelowMarketLeaseAmortizationIncomeRemainderOfFiscalYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization income for lease with finite life acquired as part of real property acquisition at below market lease rate expected to be recognized in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Below Market Lease, Amortization Income, Remainder of Fiscal Year", "terseLabel": "Below market leases, amortization income, remainder 2022" } } }, "localname": "BelowMarketLeaseAmortizationIncomeRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BelowMarketLeaseAmortizationIncomeYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization income for lease with finite life acquired as part of real property acquisition at below market lease rate expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Below Market Lease, Amortization Income, Year Four", "terseLabel": "Below market leases, amortization income, 2026" } } }, "localname": "BelowMarketLeaseAmortizationIncomeYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BelowMarketLeaseAmortizationIncomeYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization income for lease with finite life acquired as part of real property acquisition at below market lease rate expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Below Market Lease, Amortization Income, Year Three", "terseLabel": "Below market leases, amortization income, 2025" } } }, "localname": "BelowMarketLeaseAmortizationIncomeYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BelowMarketLeaseAmortizationIncomeYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization income for lease with finite life acquired as part of real property acquisition at below market lease rate expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Below Market Lease, Amortization Income, Year Two", "terseLabel": "Below market leases, amortization income, 2024" } } }, "localname": "BelowMarketLeaseAmortizationIncomeYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r357", "r359" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r357", "r359", "r395", "r396" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r394" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "negatedTerseLabel": "Acquisition and transaction related", "terseLabel": "Acquisition and transaction related" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Amount" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r18", "r33", "r115" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash, cash equivalents, end of period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r108", "r115", "r120" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period", "totalLabel": "Cash, cash equivalents and restricted cash, end of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r108", "r467" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r127", "r130", "r153", "r154", "r155", "r157", "r159", "r167", "r168", "r169", "r221", "r251", "r256", "r257", "r258", "r264", "r265", "r305", "r306", "r310", "r314", "r466", "r632" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical", "http://www.thehealthcarereit2.com/role/CoverPage", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number or rights per share (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Distribution declared on common stock (in usd per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockDividendsShares": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits.", "label": "Common Stock Dividends, Shares", "terseLabel": "Distributions declared in common stock (in shares)", "verboseLabel": "Share increase from stock dividends (in shares)" } } }, "localname": "CommonStockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r137", "r138", "r445" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in usd per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r27", "r321" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r27", "r517" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.01 par value, 300,000,000 shares authorized, 100,737,224 shares and 99,281,754 shares issued and outstanding as of March\u00a031, 2022 and December\u00a031, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonUnitIssuanceValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stated value of common units of ownership issued by a limited liability company (LLC).", "label": "Common Unit, Issuance Value", "terseLabel": "Units issued" } } }, "localname": "CommonUnitIssuanceValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r72", "r74", "r75", "r85", "r562", "r583" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive (loss) income attributable to common stockholders" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r84", "r98", "r561", "r582" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r176", "r177", "r217", "r463", "r464", "r607" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r176", "r177", "r217", "r463", "r464", "r600", "r607" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r176", "r177", "r217", "r463", "r464", "r600", "r607" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r176", "r177", "r217", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r174", "r176", "r177", "r178", "r463", "r465", "r607" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r176", "r177", "r217", "r463", "r464", "r607" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r122", "r402" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAndExpensesRelatedParty": { "auth_ref": [ "r94" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.", "label": "Costs and Expenses, Related Party", "terseLabel": "Operating fees to related parties" } } }, "localname": "CostsAndExpensesRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r126", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r283", "r290", "r291", "r293", "r301" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Credit Facilities" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r21", "r22", "r23", "r129", "r135", "r266", "r267", "r268", "r269", "r270", "r271", "r273", "r279", "r280", "r281", "r282", "r284", "r285", "r286", "r287", "r288", "r289", "r297", "r298", "r299", "r300", "r482", "r551", "r553", "r569" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r23", "r294", "r553", "r569" ], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Outstanding loan amount", "totalLabel": "Total" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentCollateralAmount": { "auth_ref": [ "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets pledged to secure a debt instrument.", "label": "Debt Instrument, Collateral Amount", "terseLabel": "Debt instrument, collateral amount" } } }, "localname": "DebtInstrumentCollateralAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r281", "r297", "r298", "r460" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Debt instrument, fair value disclosure" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r39", "r296", "r479", "r482" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r40", "r129", "r135", "r266", "r267", "r268", "r269", "r270", "r271", "r273", "r279", "r280", "r281", "r282", "r284", "r285", "r286", "r287", "r288", "r289", "r297", "r298", "r299", "r300", "r482" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r40", "r129", "r135", "r266", "r267", "r268", "r269", "r270", "r271", "r273", "r279", "r280", "r281", "r282", "r284", "r285", "r286", "r287", "r288", "r289", "r292", "r297", "r298", "r299", "r300", "r322", "r325", "r326", "r327", "r478", "r479", "r482", "r483", "r568" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r279", "r478", "r479", "r480", "r481", "r483" ], "calculation": { "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "negatedTerseLabel": "Mortgage premiums and discounts, net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of deferred costs.", "label": "Deferred Costs", "terseLabel": "Deferred costs, net" } } }, "localname": "DeferredCostsCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r36", "r279", "r480" ], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails": { "order": 2.0, "parentTag": "hct_LongtermLineofCreditIncludingFinancingCosts", "weight": -1.0 }, "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Deferred financing costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRentCredit": { "auth_ref": [ "r484", "r500" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of rental payment required by lease over rental income recognized.", "label": "Deferred Rent Credit", "terseLabel": "Deferred rent" } } }, "localname": "DeferredRentCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRentReceivablesNetNoncurrent": { "auth_ref": [ "r44", "r485", "r500" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of rental income recognized over rental payment required by lease, classified as noncurrent.", "label": "Deferred Rent Receivables, Net, Noncurrent", "terseLabel": "Straight-line rent receivable, net" } } }, "localname": "DeferredRentReceivablesNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r387" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Deferred tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r113", "r236" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 6.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "negatedTerseLabel": "Depreciation and amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r113", "r190" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.", "label": "Depreciation, Depletion, and Amortization [Policy Text Block]", "terseLabel": "Depreciation and Amortization" } } }, "localname": "DepreciationDepletionAndAmortizationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "auth_ref": [ "r47", "r59", "r423" ], "calculation": { "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Asset, Fair Value, Gross Liability", "negatedTerseLabel": "Gross Amounts Offset in the Consolidated Balance Sheet", "terseLabel": "Gross Amounts of Recognized (Liabilities)" } } }, "localname": "DerivativeAssetFairValueGrossLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r48", "r52", "r57", "r460" ], "calculation": { "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": 3.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "totalLabel": "Net Amounts of Assets presented in the Consolidated Balance Sheet" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAverageVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average variable interest rate related to the group of interest rate derivatives.", "label": "Derivative, Average Variable Interest Rate", "terseLabel": "Derivative, Average Variable Interest Rate" } } }, "localname": "DerivativeAverageVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeCapInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cap rate on an interest rate derivative such as an interest rate cap or collar. If market rates exceed the cap rate, a payment or receipt is triggered on the contract.", "label": "Derivative, Cap Interest Rate", "terseLabel": "Interest rate cap" } } }, "localname": "DerivativeCapInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeCollateralObligationToReturnCash": { "auth_ref": [ "r49", "r53", "r55", "r439" ], "calculation": { "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": 3.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.", "label": "Derivative, Collateral, Obligation to Return Cash", "negatedTerseLabel": "Gross Amounts Not Offset in the Statement of Financial Position, Cash Collateral Received" } } }, "localname": "DerivativeCollateralObligationToReturnCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeCollateralObligationToReturnSecurities": { "auth_ref": [ "r49", "r53", "r55" ], "calculation": { "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to return securities collateral under master netting arrangements that have not been offset against derivative assets.", "label": "Derivative, Collateral, Obligation to Return Securities", "negatedTerseLabel": "Gross Amounts Not Offset in the Statement of Financial Position, Financial Instruments" } } }, "localname": "DerivativeCollateralObligationToReturnSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r46", "r57", "r58", "r423", "r530" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "terseLabel": "Derivative assets, at fair value", "verboseLabel": "Gross Amounts of Recognized Assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r48", "r52", "r60", "r440" ], "calculation": { "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails": { "order": 1.0, "parentTag": "us-gaap_FairValueNetAssetLiability", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Amount Not Offset Against Collateral", "terseLabel": "Derivative assets, at fair value" } } }, "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": { "auth_ref": [ "r53", "r438" ], "calculation": { "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after effects of master netting arrangements, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against an obligation to return collateral. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset, Fair Value, Amount Offset Against Collateral", "totalLabel": "Net Amount" } } }, "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r46", "r57", "r58", "r423", "r530" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "negatedTerseLabel": "Gross Amounts of Recognized (Liabilities)", "terseLabel": "Derivative liabilities, at fair value" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r48", "r52", "r60", "r440" ], "calculation": { "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails": { "order": 2.0, "parentTag": "us-gaap_FairValueNetAssetLiability", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Amount Not Offset Against Collateral", "negatedTerseLabel": "Derivative liabilities, at fair value" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": { "auth_ref": [ "r53", "r438" ], "calculation": { "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after effects of master netting arrangements, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against the right to receive collateral. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Fair Value, Amount Offset Against Collateral", "negatedTotalLabel": "Net Amount" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFinancialInstrumentsAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).", "label": "Derivative Financial Instruments, Assets [Member]", "terseLabel": "Derivative assets, at fair value" } } }, "localname": "DerivativeFinancialInstrumentsAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.", "label": "Derivative Financial Instruments, Liabilities [Member]", "terseLabel": "Derivative liabilities, at fair value" } } }, "localname": "DerivativeFinancialInstrumentsLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r57", "r421", "r424", "r429", "r433" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r444", "r448" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivatives and Hedging Activities" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "auth_ref": [ "r428", "r430" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 10.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "negatedTerseLabel": "Gains on non-designated derivative instruments", "terseLabel": "Gains on non-designated derivative instruments", "verboseLabel": "Gains on non-designated derivatives" } } }, "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r48", "r52", "r57", "r460" ], "calculation": { "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedTotalLabel": "Net Amounts of Assets presented in the Consolidated Balance Sheet" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesOffsettingDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNetLiabilityPositionAggregateFairValue": { "auth_ref": [ "r435" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the reporting period. For nonderivative instruments that are designated and qualify as hedging instruments, the fair value amounts are the carrying value of the nonderivative hedging instrument, including the adjustment for the foreign currency transaction gain (loss) on that instrument.", "label": "Derivative, Net Liability Position, Aggregate Fair Value", "negatedTerseLabel": "Derivative, net liability position, aggregate fair value" } } }, "localname": "DerivativeNetLiabilityPositionAggregateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r415", "r417" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional Amount", "verboseLabel": "Notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNumberOfInstrumentsHeld": { "auth_ref": [ "r415", "r417" ], "lang": { "en-us": { "role": { "documentation": "The number of derivative instruments of a particular group held by the entity.", "label": "Derivative, Number of Instruments Held", "terseLabel": "Number of Instruments", "verboseLabel": "Number of instruments" } } }, "localname": "DerivativeNumberOfInstrumentsHeld", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r414", "r416", "r417", "r418", "r419", "r426", "r429", "r437", "r441", "r442", "r444" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives designated as hedging instruments:" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Equity-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r364", "r375" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Restricted Share Award Activity" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetImpairmentsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetImpairmentsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r235", "r243" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r13", "r233", "r243" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]", "terseLabel": "Assets held for sale" } } }, "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Consideration", "terseLabel": "Aggregate contract sale price" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r357", "r359" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r328", "r566" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedTerseLabel": "Distributions declared in common stock" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r22", "r24", "r552", "r571" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Distributions payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r328", "r566" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 13.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedLabel": "Distributions declared on preferred stock", "negatedTerseLabel": "Allocation for preferred stock" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromAffiliates": { "auth_ref": [ "r509", "r511", "r581" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Due from Affiliates", "terseLabel": "Due from affiliates" } } }, "localname": "DueFromAffiliates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r132", "r254", "r256", "r257", "r263", "r264", "r265", "r509", "r556", "r581" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Due from Related Parties", "verboseLabel": "Prepaid expenses and other assets, due from related parties" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r132", "r254", "r256", "r257", "r263", "r264", "r265", "r509", "r558", "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "terseLabel": "Accounts payable and accrued expenses, due to related parties" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r86", "r142", "r143", "r144", "r145", "r146", "r150", "r153", "r157", "r158", "r159", "r163", "r164", "r446", "r447", "r563", "r584" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss per common share attributable to common stockholders - Basic (in usd per share)", "verboseLabel": "Basic net loss per share (in usd per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofBasicandDilutedNetLossPerShareComputationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r86", "r142", "r143", "r144", "r145", "r146", "r153", "r157", "r158", "r159", "r163", "r164", "r446", "r447", "r563", "r584" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss per common share attributable to common stockholders - Diluted (in usd per share)", "verboseLabel": "Diluted net loss per share (in usd per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofBasicandDilutedNetLossPerShareComputationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r160", "r161", "r162", "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r374" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Nonvested awards, compensation cost not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Nonvested awards, compensation cost not yet recognized, period for recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r77", "r78", "r79", "r137", "r138", "r139", "r141", "r147", "r149", "r166", "r222", "r321", "r328", "r376", "r377", "r378", "r390", "r391", "r445", "r468", "r469", "r470", "r471", "r472", "r474", "r595", "r596", "r597", "r634" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EscrowDepositsRelatedToPropertySales": { "auth_ref": [ "r117", "r118", "r119" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Escrow deposits related to property sales in noncash investing and financing activities.", "label": "Escrow Deposits Related to Property Sales", "terseLabel": "Escrow deposits" } } }, "localname": "EscrowDepositsRelatedToPropertySales", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r281", "r297", "r298", "r460" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair\u00a0Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r449", "r450", "r451", "r456" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r449", "r450", "r451", "r455", "r456" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of Recurring Fair Value Measurements" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r449", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r449", "r461" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Summary of Fair Value by Balance Sheet" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r281", "r297", "r298", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r356", "r450", "r521", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r281", "r297", "r298", "r449", "r457" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r449", "r450", "r452", "r453", "r458" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r281", "r297", "r298" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r281", "r348", "r349", "r354", "r356", "r450", "r521" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r281", "r297", "r298", "r348", "r349", "r354", "r356", "r450", "r522" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r281", "r297", "r298", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r356", "r450", "r523" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r281", "r297", "r298", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r356", "r521", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r454", "r458" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetAssetLiability": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset after deduction of liability.", "label": "Fair Value, Net Asset (Liability)", "totalLabel": "Total" } } }, "localname": "FairValueNetAssetLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsAssetsMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Direct Financing Leases" } } }, "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r487", "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Total present value of minimum lease payments" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Summary of Finance Lease Maturities" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": 6.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.", "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2022 (remainder)" } } }, "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes finance lease liability.", "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible List]" } } }, "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: amounts representing interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r230" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "2022 (remainder)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r230" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r230" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r230" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r225", "r226", "r228", "r231", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r225", "r227" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r228", "r534" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Acquired intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and Fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": { "auth_ref": [ "r89", "r90", "r113", "r559", "r585", "r588", "r589", "r590" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 9.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.", "label": "Gains (Losses) on Sales of Investment Real Estate", "negatedTerseLabel": "Losses on sale of real estate investments, net", "terseLabel": "Losses on sale of real estate investments", "verboseLabel": "Gain (loss) on sale of real estate investments" } } }, "localname": "GainsLossesOnSalesOfInvestmentRealEstate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r95" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "negatedTerseLabel": "General and administrative", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r175", "r607" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r92", "r130", "r195", "r201", "r205", "r208", "r211", "r221", "r251", "r252", "r253", "r256", "r257", "r258", "r260", "r262", "r264", "r265", "r466" ], "calculation": { "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Net operating income" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r418", "r434" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfRealEstate": { "auth_ref": [ "r113", "r239" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value.", "label": "Impairment of Real Estate", "negatedLabel": "Impairment charges", "terseLabel": "Impairment charges" } } }, "localname": "ImpairmentOfRealEstate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetImpairmentsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r232", "r245" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r83", "r195", "r201", "r205", "r208", "r211", "r548", "r560", "r565", "r586" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r357", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetImpairmentsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r3", "r5", "r6", "r7", "r8", "r9", "r10", "r12", "r14", "r15", "r16", "r243", "r244" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetImpairmentsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r240", "r246" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r131", "r148", "r149", "r193", "r384", "r392", "r393", "r587" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 11.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax expense", "negatedTerseLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r76", "r382", "r383", "r385", "r386", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r110", "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r112" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable, accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r112" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Straight-line rent receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r112" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Deferred rent" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r112" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedTerseLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest and Other Income", "terseLabel": "Interest and other income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r81", "r189", "r477", "r480", "r564" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 7.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Total amount of interest expense presented in the\u2028consolidated statements of operations and comprehensive gain (loss)", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]", "terseLabel": "Interest Expense" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r105", "r109", "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCapMember": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.", "label": "Interest Rate Cap [Member]", "terseLabel": "Interest rate caps" } } }, "localname": "InterestRateCapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings.", "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net", "negatedLabel": "Cash flow hedge reclassification current", "negatedTerseLabel": "Unamortized portion remaining in accumulated other comprehensive (loss) income" } } }, "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "auth_ref": [ "r443" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.", "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net", "negatedTerseLabel": "Cash flow hedge reclassification in next twelve months" } } }, "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r57", "r348", "r431" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest Rate Contract" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate \u201cpay-fixed\u201d swaps" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Land": { "auth_ref": [ "r19", "r34" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandImprovementsMember": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to real estate held.", "label": "Land Improvements [Member]", "terseLabel": "Land Improvements" } } }, "localname": "LandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesAcquiredInPlaceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the amount of value allocated by a lessor (acquirer) to lease agreements which exist at acquisition of a leased property. Such amount may include the value assigned to tenant relationships and excludes the market adjustment component of the value assigned for above or below-market leases acquired.", "label": "Leases, Acquired-in-Place [Member]", "terseLabel": "In-place lease assets" } } }, "localname": "LeasesAcquiredInPlaceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Accounting for Leases, Lessee Accounting" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Summary of Operating Lease Maturities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2022 (remainder)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r497" ], "calculation": { "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: amounts representing interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorLeasesPolicyTextBlock": { "auth_ref": [ "r501", "r503", "r504", "r505" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.", "label": "Lessor, Leases [Policy Text Block]", "terseLabel": "Accounting for Leases, Lessor Accounting" } } }, "localname": "LessorLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]", "terseLabel": "Future\u00a0 Base\u00a0Rent\u00a0Payments" } } }, "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r502" ], "calculation": { "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor for operating lease.", "label": "Lessor, Operating Lease, Payments to be Received", "totalLabel": "Total" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "auth_ref": [ "r502" ], "calculation": { "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails": { "order": 5.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Four", "terseLabel": "2025" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.", "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Schedule of Future Base Rent Payments" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r502" ], "calculation": { "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails": { "order": 2.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year One", "terseLabel": "2022" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear": { "auth_ref": [ "r502" ], "calculation": { "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails": { "order": 1.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year", "terseLabel": "2022 (remainder)" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r502" ], "calculation": { "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails": { "order": 4.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Three", "terseLabel": "2024" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r502" ], "calculation": { "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails": { "order": 3.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Two", "terseLabel": "2023" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesLessorMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r38", "r130", "r203", "r221", "r251", "r252", "r253", "r256", "r257", "r258", "r260", "r262", "r264", "r265", "r401", "r408", "r409", "r466", "r515", "r516" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r32", "r130", "r221", "r466", "r517", "r555", "r576" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LimitedPartnersCapitalAccountByClassAxis": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of limited partnership interests.", "label": "Limited Partners' Capital Account by Class [Axis]", "terseLabel": "Limited Partners' Capital Account by Class [Axis]" } } }, "localname": "LimitedPartnersCapitalAccountByClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LimitedPartnersCapitalAccountClassDomain": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Description of the type or class of limited partner's capital account.", "label": "Limited Partners' Capital Account, Class [Domain]", "terseLabel": "Limited Partners' Capital Account, Class [Domain]" } } }, "localname": "LimitedPartnersCapitalAccountClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The number of limited partner units outstanding.", "label": "Limited Partners' Capital Account, Units Outstanding", "terseLabel": "Limited partner units (in shares)" } } }, "localname": "LimitedPartnersCapitalAccountUnitsOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r23", "r553", "r569" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails": { "order": 1.0, "parentTag": "hct_LongtermLineofCreditIncludingFinancingCosts", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Outstanding balance", "verboseLabel": "Credit facilities, net" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r37", "r129" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r37", "r129" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Unused borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r37", "r129" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Credit Facility" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r23", "r280", "r295", "r297", "r298", "r553", "r572" ], "calculation": { "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Mortgage notes payable, net" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r135", "r249", "r285" ], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r135", "r249", "r285" ], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails": { "order": 5.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r135", "r249", "r285" ], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails": { "order": 4.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r135", "r249", "r285" ], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r135" ], "calculation": { "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "verboseLabel": "2022 (remainder)" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtPercentageBearingFixedInterestAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.", "label": "Long-term Debt, Percentage Bearing Fixed Interest, Amount", "terseLabel": "Debt, percentage bearing fixed interest, amount" } } }, "localname": "LongtermDebtPercentageBearingFixedInterestAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r40", "r250" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinimumNetWorthRequiredForCompliance": { "auth_ref": [ "r602", "r603", "r604", "r605" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum net worth required for mortgage banking as defined by regulatory framework.", "label": "Banking Regulation, Mortgage Banking, Net Worth, Minimum", "terseLabel": "Minimum net worth required for compliance" } } }, "localname": "MinimumNetWorthRequiredForCompliance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r45", "r130", "r221", "r251", "r256", "r257", "r258", "r264", "r265", "r466", "r554", "r575" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interests", "totalLabel": "Total Non-controlling interests", "verboseLabel": "Third Party Net Investment Amount" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedTerseLabel": "Distributions to non-controlling interest holders", "terseLabel": "Distributions" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDisclosureTextBlock": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest Disclosure [Text Block]", "terseLabel": "Non-controlling Interests" } } }, "localname": "MinorityInterestDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterests" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterestInOperatingPartnerships": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails": { "order": 1.0, "parentTag": "us-gaap_MinorityInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of the equity interests owned by noncontrolling partners in an operating partnership included in the entity's consolidated financial statements.", "label": "Noncontrolling Interest in Operating Partnerships", "terseLabel": "Total Non-controlling Interests in the Operating Partnership" } } }, "localname": "MinorityInterestInOperatingPartnerships", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Noncontrolling Interest [Line Items]", "terseLabel": "Noncontrolling Interest [Line Items]" } } }, "localname": "MinorityInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Non-Controlling Ownership Percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestTable": { "auth_ref": [ "r45", "r93", "r398", "r407" ], "lang": { "en-us": { "role": { "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest [Table]", "terseLabel": "Noncontrolling Interest [Table]" } } }, "localname": "MinorityInterestTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsBalanceSheetBreakdownDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MortgageNotesPayableDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for mortgage notes payable.", "label": "Mortgage Notes Payable Disclosure [Text Block]", "terseLabel": "Mortgage Notes Payable, Net" } } }, "localname": "MortgageNotesPayableDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_MortgagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.", "label": "Mortgages [Member]", "terseLabel": "Mortgages", "verboseLabel": "Gross mortgage notes payable and mortgage premium and discounts, net" } } }, "localname": "MortgagesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetMortgageNotesDetails", "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r108" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r108" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r108", "r111", "r114" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r70", "r73", "r79", "r148", "r149", "r404", "r411" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 12.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net loss (income) attributable to non-controlling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r142", "r143", "r144", "r145", "r150", "r151", "r156", "r159", "r195", "r201", "r205", "r208", "r211" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net loss attributable to common stockholders", "totalLabel": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofBasicandDilutedNetLossPerShareComputationDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Abstract]", "terseLabel": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r137", "r138", "r139", "r328", "r397" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives not designated as hedging instruments:" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesBalanceSheetClassificationDetails", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesSummaryofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r96" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expenses" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfBusinessesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of businesses acquired by the entity during the period.", "label": "Number of Businesses Acquired", "terseLabel": "Number of properties purchased" } } }, "localname": "NumberOfBusinessesAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfRealEstateProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of real estate properties owned as of the balance sheet date.", "label": "Number of Real Estate Properties", "terseLabel": "Number of properties" } } }, "localname": "NumberOfRealEstateProperties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails", "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingNarrativeDetails", "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of states the entity operates in as of the balance sheet date.", "label": "Number of States in which Entity Operates", "terseLabel": "Number of states properties are located in" } } }, "localname": "NumberOfStatesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OffMarketLeaseUnfavorable": { "auth_ref": [ "r41" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents a liability associated with the acquisition of an off-market lease when the terms of the lease are unfavorable to the market terms for the lease at the date of acquisition.", "label": "Off-market Lease, Unfavorable", "terseLabel": "Market lease intangible liabilities, net" } } }, "localname": "OffMarketLeaseUnfavorable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsTableTextBlock": { "auth_ref": [ "r50", "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Assets [Table Text Block]", "terseLabel": "Offsetting Assets" } } }, "localname": "OffsettingAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "hct_OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r195", "r201", "r205", "r208", "r211" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r493", "r498" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r489" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Property operating and maintenance" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Operating Leases" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r487" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total present value of minimum lease payments", "verboseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesScheduleofFutureMinimumRentalPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r490", "r494" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating lease payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r486" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r496", "r498" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate, percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r495", "r498" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r200", "r201", "r202", "r203", "r205", "r211" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r17", "r413" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r68", "r77", "r78", "r80", "r468", "r470", "r474" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Other comprehensive gain (loss), before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r61", "r66" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Unrealized gain on designated derivatives", "verboseLabel": "Amount of gain recognized in accumulated other comprehensive loss on interest rate derivatives" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r66", "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "terseLabel": "Amount of gain (loss) reclassified from accumulated other comprehensive income into income as interest expense" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesDerivativesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r71", "r74", "r77", "r78", "r80", "r84", "r321", "r468", "r473", "r474", "r561", "r582" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Unrealized gain (loss) on designated derivative" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other intangible assets" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r87" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "terseLabel": "Interest and other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Stockholders Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": { "auth_ref": [ "r103", "r107" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.", "label": "Payments for Derivative Instrument, Financing Activities", "negatedLabel": "Payments for derivative instruments" } } }, "localname": "PaymentsForDerivativeInstrumentFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLeaseCommissions": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for lease commissions incurred.", "label": "Payments for Lease Commissions", "negatedTerseLabel": "Deposits for real estate investments" } } }, "localname": "PaymentsForLeaseCommissions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r101" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "negatedTerseLabel": "Distributions to non-controlling interest holders", "terseLabel": "Distributions to non-controlling interest holders" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r101" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedTerseLabel": "Dividends paid on preferred stock" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r104" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedTerseLabel": "Payments of deferred financing costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r104" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedTerseLabel": "Preferred stock issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": { "auth_ref": [ "r100" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Payments to Acquire Other Property, Plant, and Equipment", "negatedTerseLabel": "Capital expenditures and other assets acquired" } } }, "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r100" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "terseLabel": "Total capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRealEstate": { "auth_ref": [ "r100" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.", "label": "Payments to Acquire Real Estate", "negatedTerseLabel": "Property acquisitions and development costs" } } }, "localname": "PaymentsToAcquireRealEstate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "terseLabel": "Payments to noncontrolling interests" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r364", "r375" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/FairValueofFinancialInstrumentsCarryingAmountsandFairValuesofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Preferred stock, dividend rate, percentage" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.", "label": "Preferred Stock, Dividends Per Share, Declared", "terseLabel": "Distributions declared on preferred stock (in usd per share)" } } }, "localname": "PreferredStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r26", "r127", "r310", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Preferred Stock, Liquidation Preference Per Share", "terseLabel": "Preferred stock, liquidation preference (in usd per share)" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r26", "r305" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in usd per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r26", "r305" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r26", "r517" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredUnitsIssued": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The number of preferred units issued.", "label": "Preferred Units, Issued", "terseLabel": "Number of Preferred OP Units issued (in shares)" } } }, "localname": "PreferredUnitsIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other assets", "verboseLabel": "Prepaid expenses and other assets (including $172 and $929 due from related parties as of March\u00a031, 2022 and December\u00a031, 2021, respectively)" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": { "auth_ref": [ "r99" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.", "label": "Proceeds from Sale of Real Estate Held-for-investment", "terseLabel": "Proceeds from sales of real estate investments" } } }, "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r16", "r70", "r73", "r79", "r106", "r130", "r140", "r148", "r149", "r195", "r201", "r205", "r208", "r211", "r221", "r251", "r252", "r253", "r256", "r257", "r258", "r260", "r262", "r264", "r265", "r399", "r403", "r405", "r411", "r412", "r447", "r466", "r565" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r35", "r238" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r20", "r237" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, plant and equipment, useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RealEstateDisclosureTextBlock": { "auth_ref": [ "r620", "r621", "r622", "r624", "r626" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures.", "label": "Real Estate Disclosure [Text Block]", "terseLabel": "Real Estate Investments, Net" } } }, "localname": "RealEstateDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": { "auth_ref": [ "r577" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes.", "label": "Real Estate Investment Property, Accumulated Depreciation", "negatedTerseLabel": "Less: accumulated depreciation and amortization" } } }, "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyAtCost": { "auth_ref": [ "r578" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.", "label": "Real Estate Investment Property, at Cost", "terseLabel": "Total real estate investments, at cost", "totalLabel": "Total real estate investments, at cost" } } }, "localname": "RealEstateInvestmentPropertyAtCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyAtCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate Investment Property, at Cost [Abstract]", "terseLabel": "Investments in real estate, net:" } } }, "localname": "RealEstateInvestmentPropertyAtCostAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstateInvestmentPropertyNet": { "auth_ref": [ "r578" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.", "label": "Real Estate Investment Property, Net", "terseLabel": "Investments in real estate:", "totalLabel": "Total real estate investments, net", "verboseLabel": "Net Real Estate Assets Subject to Investment Arrangement" } } }, "localname": "RealEstateInvestmentPropertyNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate Investments, Net [Abstract]", "terseLabel": "Real Estate Investments, Net [Abstract]" } } }, "localname": "RealEstateInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RealEstatePolicyTextBlock": { "auth_ref": [ "r476", "r608" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for entities that primarily develop and then sell real property at retail or otherwise.", "label": "Real Estate, Policy [Policy Text Block]", "terseLabel": "Investments in Real Estate" } } }, "localname": "RealEstatePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RealEstatePropertiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Real Estate Properties [Line Items]", "terseLabel": "Real estate investments" } } }, "localname": "RealEstatePropertiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r68", "r77", "r78", "r80", "r468", "r472", "r474" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Amount of gain (loss) reclassified from accumulated other comprehensive gain (loss)" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.", "label": "Redeemable Noncontrolling Interest [Table Text Block]", "terseLabel": "Summary of Non-controlling Interest" } } }, "localname": "RedeemableNoncontrollingInterestTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r355", "r508", "r509" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r508", "r512" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Transaction amount" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r355", "r508", "r509", "r512" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionDueFromToRelatedParty": { "auth_ref": [ "r132", "r254", "r256", "r257", "r263", "r264", "r265", "r509" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.", "label": "Related Party Transaction, Due from (to) Related Party", "terseLabel": "Payable (Receivable)" } } }, "localname": "RelatedPartyTransactionDueFromToRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r508" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "netLabel": "Expenses incurred" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.", "label": "Related Party Transaction, Other Revenues from Transactions with Related Party", "negatedTerseLabel": "Revenues incurred" } } }, "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r355", "r508", "r512", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r506", "r507", "r509", "r513", "r514" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions and Arrangements" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r102" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedTerseLabel": "Payments on mortgage notes payable" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r120", "r549", "r573" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash", "verboseLabel": "Restricted cash, end of period" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Unvested Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r137", "r138", "r139", "r141", "r147", "r149", "r222", "r376", "r377", "r378", "r390", "r391", "r445", "r595", "r597" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Distributions in excess of accumulated earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r124", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r346" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r124", "r125" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "CARES Act Grants" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r82", "r130", "r186", "r187", "r200", "r206", "r207", "r213", "r214", "r217", "r221", "r251", "r252", "r253", "r256", "r257", "r258", "r260", "r262", "r264", "r265", "r466", "r565" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "hct_OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments", "weight": 1.0 }, "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenue from tenants" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/CreditFacilitiesSummaryofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Proceeds received on offering" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Preferred stock, number of shares issued in public offering (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r176", "r217" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetGeographicConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r68", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r395", "r396" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of Business Acquisition" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Derivatives Included in AOCI" } } }, "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r40", "r135", "r297", "r299", "r322", "r325", "r326", "r327", "r478", "r479", "r483", "r568" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/MortgageNotesPayableNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r414", "r416", "r417", "r418", "r419", "r426", "r429", "r437", "r441" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Summary of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Balance Sheet Location" } } }, "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/DerivativesandHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r3", "r5", "r6", "r7", "r8", "r9", "r10", "r12", "r14", "r15", "r16", "r243", "r244" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Real Estate Sales" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Basic and Diluted Net Loss Per Share Computation" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/NetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r225", "r227", "r534" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofAmortizationandAccretionRecognizedDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetSummaryofIntangibleAssetsandLiabilitiesFutureAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r225", "r227" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "terseLabel": "Schedule of Credit Facilities" } } }, "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Long-term Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRealEstatePropertiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning real estate properties and units within those properties by ownership of the property.", "label": "Schedule of Real Estate Properties [Table]", "terseLabel": "Schedule of Real Estate Properties [Table]" } } }, "localname": "ScheduleOfRealEstatePropertiesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r510", "r512" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesPaidinConnectionWiththeOperationsoftheCompanyIncurredForgivenandPayableDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsFeesandParticipationsPaidinConnectionwiththeLiquidationorListingoftheCompanysRealEstateAssetsDetails", "http://www.thehealthcarereit2.com/role/RelatedPartyTransactionsandArrangementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r91", "r216" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Revenue" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r195", "r198", "r204", "r223" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r195", "r198", "r204", "r223" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r364", "r375" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r42", "r127", "r167", "r168", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r310", "r314", "r319", "r322", "r323", "r324", "r325", "r326", "r327", "r328" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "auth_ref": [ "r331", "r332", "r333", "r334" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table Text Block]", "terseLabel": "Class of Treasury Stock" } } }, "localname": "ScheduleOfTreasuryStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Projected Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r23", "r553", "r572" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "verboseLabel": "Mortgage notes payable, net" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r182", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r200", "r201", "r202", "r203", "r205", "r206", "r207", "r208", "r209", "r211", "r217", "r247", "r248", "r591" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r182", "r184", "r185", "r195", "r199", "r205", "r209", "r210", "r211", "r212", "r213", "r216", "r217", "r218" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Individual business acquisitions" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetAcquiredAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r112" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Equity-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Restricted share vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Shares of Common Stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending balance (in usd per share)", "periodStartLabel": "Beginning balance (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Issue Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in shares)", "terseLabel": "Unvested restricted stock (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum", "terseLabel": "Maximum authorized amount as a percentage of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r361", "r367" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails", "http://www.thehealthcarereit2.com/role/EquityBasedCompensationSummaryofActivityDetails", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in shares)", "terseLabel": "Shares outstanding (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r121", "r136" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r4", "r182", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r200", "r201", "r202", "r203", "r205", "r206", "r207", "r208", "r209", "r211", "r217", "r223", "r242", "r247", "r248", "r591" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofCapitalExpendituresbySegmentDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivityDetails", "http://www.thehealthcarereit2.com/role/SegmentReportingReconciliationofSegmentActivitytoAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r25", "r26", "r27", "r127", "r130", "r153", "r154", "r155", "r157", "r159", "r167", "r168", "r169", "r221", "r251", "r256", "r257", "r258", "r264", "r265", "r305", "r306", "r310", "r314", "r321", "r466", "r632" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical", "http://www.thehealthcarereit2.com/role/CoverPage", "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r43", "r77", "r78", "r79", "r137", "r138", "r139", "r141", "r147", "r149", "r166", "r222", "r321", "r328", "r376", "r377", "r378", "r390", "r391", "r445", "r468", "r469", "r470", "r471", "r472", "r474", "r595", "r596", "r597", "r634" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsNarrativeDetails", "http://www.thehealthcarereit2.com/role/NoncontrollingInterestsSummaryofNoncontrollingInterestsDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r137", "r138", "r139", "r166", "r533" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITYParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockDividendsShares": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits.", "label": "Stock Dividends, Shares", "terseLabel": "Stock dividends (in shares)" } } }, "localname": "StockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r117", "r118", "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Common stock issued through stock dividends" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the shareholders to reinvest dividends paid to them by the entity on new issues of stock by the entity.", "label": "Stock Issued During Period, Shares, Dividend Reinvestment Plan", "terseLabel": "Common stock issued through distribution reinvestment plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesDividendReinvestmentPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Stock issued during period, issued for services (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/EquityBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r26", "r27", "r321", "r328" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued during period, shares, new issues (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r26", "r27", "r321", "r328" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of Preferred Stock, net" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r26", "r27", "r328", "r363", "r372" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Share-based compensation, net" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, maximum authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r27", "r30", "r31", "r130", "r220", "r221", "r466", "r517" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r78", "r130", "r137", "r138", "r139", "r141", "r147", "r221", "r222", "r328", "r376", "r377", "r378", "r390", "r391", "r397", "r398", "r410", "r445", "r466", "r468", "r469", "r474", "r596", "r597", "r634" ], "calculation": { "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/AccumulatedOtherComprehensiveLossSummaryofChangesinAOCIDetails", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r128", "r306", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r328", "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r475", "r519" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r475", "r519" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r475", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r475", "r519" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesFuturePrincipalPaymentsofOutstandingDebtDetails", "http://www.thehealthcarereit2.com/role/OrganizationNarrativeDetails", "http://www.thehealthcarereit2.com/role/RealEstateInvestmentsNetNarrativeDetails", "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails", "http://www.thehealthcarereit2.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r518", "r520" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityScheduleofStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Weighted-Average Price per Share (in usd per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityCumulativeShareRepurchasesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r27", "r321", "r328" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "verboseLabel": "Number of Shares Repurchased (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/StockholdersEquityCumulativeShareRepurchasesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r170", "r171", "r172", "r173", "r179", "r180", "r181" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r152", "r159" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares outstanding - Diluted (in shares)", "verboseLabel": "Diluted weighted-average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofBasicandDilutedNetLossPerShareComputationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r150", "r159" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares outstanding - Basic (in shares)", "verboseLabel": "Basic weighted-average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.thehealthcarereit2.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSS", "http://www.thehealthcarereit2.com/role/NetLossPerShareSummaryofBasicandDilutedNetLossPerShareComputationDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 14 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3505-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r17": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r218": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r301": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.F)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r346": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r381": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r413": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624258-113959" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624258-113959" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r448": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "15", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450852&loc=d3e24871-108386" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123415192&loc=d3e39896-112707" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r499": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r514": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r520": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122596-111746" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226038-175313" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(14)(d))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(d)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(d))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123605564&loc=d3e23415-158514" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123605564&loc=d3e23439-158514" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123605587&loc=d3e23528-158515" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=d3e9120-115832" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47080-110998" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=123419364&loc=d3e24546-110282" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 5))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r620": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "970", "URI": "http://asc.fasb.org/topic&trid=2156125" }, "r621": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "972", "URI": "http://asc.fasb.org/topic&trid=2134617" }, "r622": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "974", "URI": "http://asc.fasb.org/topic&trid=2156429" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r624": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "976", "URI": "http://asc.fasb.org/topic&trid=2134846" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r626": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "978", "URI": "http://asc.fasb.org/topic&trid=2134977" }, "r627": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r628": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r629": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r630": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r631": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r632": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r633": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" } }, "version": "2.1" }